Louisiana State University

LSU Digital Commons
LSU Doctoral Dissertations

Graduate School

2017

A Presynaptic Role for Nitric Oxide at a GABAergic Synapse
John Wesley Maddox
Louisiana State University and Agricultural and Mechanical College

Follow this and additional works at: https://digitalcommons.lsu.edu/gradschool_dissertations
Part of the Life Sciences Commons

Recommended Citation
Maddox, John Wesley, "A Presynaptic Role for Nitric Oxide at a GABAergic Synapse" (2017). LSU Doctoral
Dissertations. 4450.
https://digitalcommons.lsu.edu/gradschool_dissertations/4450

This Dissertation is brought to you for free and open access by the Graduate School at LSU Digital Commons. It
has been accepted for inclusion in LSU Doctoral Dissertations by an authorized graduate school editor of LSU
Digital Commons. For more information, please contactgradetd@lsu.edu.

A PRESYNAPTIC ROLE FOR NITRIC OXIDE AT A
GABAERGIC SYNAPSE

A Dissertation
Submitted to the Graduate Faculty of the
Louisiana State University and
Agricultural and Mechanical College
in partial fulfillment of the
requirements for the degree of
Doctor of Philosophy
in
The Department of Biological Sciences

by
John Wesley Maddox
B.S., Louisiana Tech University, 2007
M.S., Louisiana Tech University, 2010
August 2017

I dedicate this work
to my parents, William and Barbara Maddox.
Without their compassion, love, and support,
this would have been impossible.

ii

ACKNOWLEDGEMENTS
I would first like to thank my graduate advisor and mentor, Dr. Evanna Gleason. I
appreciate all the knowledge, determination, and guidance she has given me
throughout my doctoral studies. Her expertise in neurophysiology will always have a
lasting impact on my career.
I would also like to thank my committee members. Conversations with you have
really helped me during my time in this program. To Dr. Jacqueline Stephens, thank you
for the western blot suggestions and hugs every time I saw you. To Dr. Ryoichi
Teruyama, thank you the use of your lab and for the western blot, electrophysiology,
and immunohistochemistry suggestions. I appreciate the time my committee members
have taken to write reference letters, listen to my talks, and to provide feedback on my
work.
Thanks to past lab members, Dr. Vijai Krishnan, Sujitha Manoj, Dr. Emily
McMains, and Dr. Merve Tekmen-Clark, who all helped me land on my feet when I first
joined the lab. Thanks to my fellow labmates: Vernon Dunn and Tyler Rodriguez. I
greatly appreciate all the feedback, trips to conference, and overall support in the lab. I
would also like to thank the undergraduates who have been in the lab, particularly Nikka
Khorsandi for the months of western blots and immunohistochemistry experiments.
Thanks to my father, William Maddox, my mother, Barbara Maddox, and my
sister Brandy Maddox for the love, support, and patience during my entire education. I
will forever be indebted to you. Thanks to my best friend and partner, Derek Haigler, for
listening to me, giving me constructive feedback, and having patience with me during
the final years of my doctoral studies. Thanks to my friends Sharla Rodrigue, Danielle

iii

Porter, Lauren Lambert-Tompkins, Zachary Tompkins, Gary Landry, Daniel Baer,
Lauren Cockerham, Karen Field, Minerva Maddox, Winston Maddox, Neil Harris, and
Leila Gray. Thank you all for the support, love, and laughter that got me through the ups
and downs during graduate studies.
Finally, I would like to thank the National Science Foundation (grant IOS1256782 to Evanna Gleason) and Sigma Xi Grant-in-Aid of Research for supporting all
my dissertation research.

iv

TABLE OF CONTENTS
ACKNOWLEDGEMENTS................................................................................................ iii
LIST OF FIGURES ......................................................................................................... vii
LIST OF ABBREVIATIONS ............................................................................................ viii
ABSTRACT ..................................................................................................................... xi
CHAPTER 1: INTRODUCTION ........................................................................................ 1
Retinal amacrine cells ........................................................................................... 2
Retinal amacrine cell signaling .............................................................................. 4
Nitric oxide in the retina ......................................................................................... 5
Regulation of nNOS and eNOS ............................................................................. 7
Nitric oxide targets ................................................................................................. 8
References ............................................................................................................ 9
CHAPTER 2: NITRIC OXIDE PROMOTES GABA RELEASE BY ACTIVATING A
VOLTAGE-INDEPENDENT CA2+ INFLUX PATHWAY IN RETINAL
AMACRINE CELLS* ................................................................................. 15
Introduction .......................................................................................................... 15
Methods ............................................................................................................... 17
Amacrine cell cultures ............................................................................... 17
Electrophysiology ...................................................................................... 18
Solutions ................................................................................................... 19
Reagents .................................................................................................. 20
Calcium imaging ....................................................................................... 21
Data analysis ............................................................................................ 21
Results ................................................................................................................. 23
SNAP increases sPSC frequency ............................................................. 23
NO-dependent increase of sPSC frequency does not require sGC
activity ............................................................................................ 23
NO-increases GABAergic sPSC frequency .............................................. 25
NO-dependent increase of sPSC frequency is not action potentialdependent ...................................................................................... 26
The role of Ca2+ ....................................................................................... 29
NO increases evoked GABAergic autaptic transmission .......................... 33
The effect of NO on sPSCs does not involve L-type VGCCs,
AMPARs or NMDARs .................................................................... 34
Clemizole blocks the NO-dependent increase in sPSC frequency and
intracellular Ca2+ ............................................................................ 36
Discussion ........................................................................................................... 39
VGCC-independent GABA release ........................................................... 40
NO and GABA release .............................................................................. 41
Role of spontaneous GABA release ......................................................... 42

v

TRPCs in ACs ........................................................................................... 42
References .......................................................................................................... 44
CHAPTER 3: TRPC5 IS REQUIRED FOR THE NO-DEPENDENT INCREASE IN
DENDRITIC CA2+ AND GABA RELEASE FROM RETINAL AMACRINE
CELLS ..................................................................................................... 50
Introduction .......................................................................................................... 50
Methods ............................................................................................................... 52
Plasmid construction ................................................................................. 52
Amacrine cell cultures and transfections .................................................. 53
Solutions ................................................................................................... 54
Reagents .................................................................................................. 55
Electrophysiology ...................................................................................... 55
Calcium imaging ....................................................................................... 56
Immunocytochemistry ............................................................................... 56
Immunohistochemistry .............................................................................. 57
Western blot .............................................................................................. 58
TRPC5 gene mutation analysis ................................................................ 59
Data analysis ............................................................................................ 60
Results ................................................................................................................. 61
PLC activity is required for the NO-dependent GABA release from retinal
ACs ................................................................................................ 61
The NO-dependent increase in sPSC frequency is sensitive to La3+ ....... 62
ML204 can block the NO-dependent increase in cytosolic Ca2+............... 64
TRPC5 is expressed in ACs in culture and retina ..................................... 67
CRISPR/Cas9-mediated dsDNA break of the TRPC5 gene reduces
TRPC5 expression ......................................................................... 67
TRPC5 is required for the NO-dependent increase in cytosolic Ca2+
and GABA release ......................................................................... 69
Discussion ........................................................................................................... 71
TRPC5 in the retina and brain .................................................................. 72
Identification of NO-dependent activation of TRPC5 ................................ 74
Effects of NO on amacrine cells ............................................................... 75
Multiple effects of NO on amacrine cell synapses .................................... 76
References .......................................................................................................... 78
CHAPTER 4: CONCLUSIONS ...................................................................................... 82
References .......................................................................................................... 86
APPENDIX: LETTER OF PERMISSION ........................................................................ 87
VITA................................................................................................................................ 88

vi

LIST OF FIGURES
1.1

Schematic of cellular and synaptic organization in the vertebrate retina ............... 2

1.2

Enzymatic NO production ...................................................................................... 6

2.1

NO increases frequency of spontaneous postsynaptic currents (sPSCs) ........... 24

2.2

NO-dependent increase of sPSCs does not require soluble guanylate cyclase
(sGC) activity ....................................................................................................... 25

2.3

NO-induced increase in GABAergic sPSC frequency does not require action
potentials ............................................................................................................. 27

2.4

NO increases intracellular Ca2+ ........................................................................... 28

2.5

The NO-dependent increase of sPSC frequency is dependent upon cytosolic
Ca2+ elevations .................................................................................................... 30

2.6

NO-dependent increase of intracellular Ca2+ is independent of intracellular
stores ................................................................................................................... 32

2.7

NO-dependent increase of sPSC frequency is independent of Ca2+ stores ........ 33

2.8

NO increases evoked autaptic GABAergic postsynaptic currents ....................... 35

2.9

L-type voltage-gated Ca2+ channels (VGCCs), AMPARs or NMDARs are not
required for the NO-dependent Ca2+ influx .......................................................... 37

2.10

Clemizole blocks the NO-dependent increase in sPSC frequency and
intracellular Ca2+ ....................................................................................... 39

3.1

PLC activity is required for the NO-dependent increase in sPSC frequency ....... 63

3.2

The NO-dependent increase in sPSC frequency is sensitive to La3+ .................. 64

3.3

The TRPC4/C5 inhibitor ML204 can block the NO-dependent increase in
cytosolic Ca2+ and sPSC frequency at higher concentrations ............................. 66

3.4

Amacrine cells in culture and adult retina express TRPC5 ................................. 68

3.5

CRISPR/Cas9-mediated TRPC5 mutagenesis reduces TRPC5 expression in
amacrine cell processes ...................................................................................... 70

3.6

Knockdown of TRPC5 eliminates the NO-dependent increase in cytosolic Ca2+
and sPSC frequency ............................................................................................ 72

3.7

NO has pre- and postsynaptic effects in ACs ...................................................... 77

vii

LIST OF ABBREVIATIONS
2-APB

2-Aminoethoxydiphenylborane

AC

amacrine cell

AMPA

α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid

ANOVA

analysis of variance

BAPTA-AM

1,2-Bis(2-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid tetrakis
(acetoxymethyl ester)

BSA

bovine serum albumin

CaM

calmodulin

cAMP

cyclic adenosine monophosphate

CAPON

carboxy-terminal PDZ ligand of nNOS

Cas9

CRISPR associated protein 9

cGMP

cyclic guanosine monophosphate

clemizole

1-[(4-Chlorophenyl)methyl]-2-(1-pyrrolidinylmethyl)-1Hbenzimidazole hydrochloride

CNS

central nervous system

CNQX

6-Cyano-7-nitroquinoxaline-2,3-dione

CPTIO

2-(4-Carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3- oxide

CRISPR

clustered regularly interspaced short palindromic repeats

DAG

diacylglycerol

D-AP5

D-(-)-2-Amino-5-phosphonopentanoic acid

DAPI

2-(4-amidinophenyl)-1H -indole-6-carboxamidine

DMSO

dimethyl sulfoxide

viii

dsDNA

double stranded DNA

eNOS

endothelial nitric oxide synthase

GABA

gamma amino butyric acid

GCL

ganglion cell layer

GFP

green fluorescent protein

hDNA

heteroduplexed DNA

HEPES

4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid

INL

inner nuclear layer

IP3

inositol trisphosphate

IPL

inner plexiform layer

KD

knock down

mGluR5

metabotropic glutamate receptor 5

ML204

4-Methyl-2-(1-piperidinyl)quinoline

nifedipine

1,4-Dihydro-2,6-dimethyl-4-(2-nitrophenyl)-3,5-pyridinedicarboxylic
acid dimethyl ester

NMDA

N-methyl-D-aspartate

nNOS

neuronal nitric oxide synthase

NO

nitric oxide

NOSIP

nitric oxide synthase interacting protein

NOSTRIN

eNOS traffic inducer

ODQ

1H-[1,2,4]Oxadiazolo[4,3-a]quinoxalin-1-one

OGB

Oregon Green 488 BAPTA-1, AM

ix

ONL

outer nuclear layer

OPL

outer plexiform layer

PCR

polymerase chain reaction

PIP2

phosphatidylinositol 4,5-bisphosphate

PLC

phospholipase C

ROI

region of interest

SDS

sodium dodecyl sulfate

sGC

soluble guanylate cyclase

SKF 96365

1-[2-(4-Methoxyphenyl)-2-[3-(4-methoxyphenyl)propoxy]ethyl-1Himidazole hydrochloride

SNAP

S-nitroso-N-acetylpenicillamine

sPSC

spontaneous postsynaptic current

T7E1

T7 endonuclease I

TBS

Tris buffered saline

tdTomato

tandem dimer of dTomato fluorescent protein

TEA-Cl

tetraethylammonium chloride

TG

thapsigargin

Tris

Tris(hydroxymethyl)aminomethane

TRPC

transient receptor potential canonical

TTX

tetrodotoxin

VGCC

voltage-gated calcium channel

x

ABSTRACT
Amacrine cells are a class of retinal interneurons that process the visual signal in
the inner retina. Several subtypes of amacrine cells express nitric oxide synthase and
produce nitric oxide (NO), making NO a possible regulator of amacrine cell function. My
dissertation research tests the hypothesis that NO alters amacrine cell GABAergic
synaptic output. To investigate this, I made whole-cell voltage clamp recordings of
cultured chick amacrine cells receiving synaptic input from other amacrine cells and
Ca2+ imaging of amacrine cell dendrites, which can be presynaptic. I find that NOdependent increases in GABAergic spontaneous postsynaptic current (sPSC) frequency
are independent of soluble guanylate cyclase and action potentials. Removal of
extracellular Ca2+ and buffering of cytosolic Ca2+ both inhibit the response to NO. In
Ca2+ imaging experiments, I confirm that NO increases dendritic Ca2+ by activating a
Ca2+ influx pathway. Neither NO-dependent dendritic Ca2+ elevation nor increase in
sPSC frequency are dependent upon Ca2+ release from stores. NO also enhances
evoked GABAergic responses, and because voltage-gated Ca2+ channel function is not
altered by NO, the enhanced evoked release is likely due to the combination of voltagedependent Ca2+ influx and the voltage-independent, NO-dependent Ca2+ influx. Insight
into the identity of the Ca2+ channel involved in the NO response was provided by
characteristics unique to the transient receptor potential canonical (TRPC) channel
subunits 4 and 5: the NO-dependent increase in sPSC frequency was dependent on
downstream activity of PLC, blocked by 2 mM La3+ and enhanced by 10 µM La3+. The
TRPC inhibitor ML204, which preferentially blocks TRPC4, had no effect on the NO
response at 10 µM, but 20 µM ML204 blocked the NO response. The TRPC inhibitor

xi

clemizole, which preferentially blocks TRPC5, blocked NO-dependent dendritic Ca2+
elevations and the increase in sPSC frequency. Genetic knockdown of TRPC5 in
cultured amacrine cells using the CRISPR/Cas9 system confirms that TRPC5 mediates
NO-dependent dendritic Ca2+ elevations and the increase in sPSC frequency. These
results suggest that NO-dependent activation of TRPC5 at amacrine cell presynaptic
sites will enhance vesicular GABA release and increase inhibition onto postsynaptic
cells.
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CHAPTER 1
INTRODUCTION
The vertebrate retina is the photosensory organ responsible for the detection of
light in vision (See Figure 1.1). On the input side of the retina, also called the outer
nuclear layer (ONL), visual signals from the environment are initiated by the patterns of
photons (for example, the different photon patterns of the text you are reading here)
interacting with photoreceptors, which are the cells responsible for converting the arrival
of photons into neural signals. On the output side of the retina, ganglion cells in the
ganglion cell layer (GCL) project their axons to the brain via the optic nerve. Ultimately,
the visual signals are sent to the visual cortex in the brain for further processing and
interpretation. Before being sent to the brain, the visual signal is processed within the
retina itself. There are 3 classes of interneurons (bipolar cells, horizontal cells and
amacrine cells) between the photoreceptors and ganglion cells that communicate with
each other to process the visual signal. The cell bodies of all interneurons lie in the
inner nuclear layer (INL). Bipolar cells complete the vertical pathway of the visual signal
between photoreceptor and ganglion cells by receiving synaptic input from
photoreceptors in the outer plexiform layer (OPL) and sending synaptic output to
ganglion cells in the inner plexiform layer (IPL). Horizontal cells interact with
photoreceptors, bipolar cells and other horizontal cells in the OPL to adjust the receptive
fields of bipolar cells. Amacrine cells (ACs) have synaptic interactions in the IPL with
bipolar cells, ganglion cells, and other ACs. The most common synaptic partner of ACs,
however, are other ACs (Marc and Liu 2000), and these are the synapses of interest in
my dissertation.
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Figure 1.1. Schematic of cellular and synaptic organization in the vertebrate retina. Light
enters the eye and transverses through all layers of the retina. Cell bodies of rod
photoreceptors (R) and cone photoreceptors (C) lie in the outer nuclear layer (ONL) and
convert the arrival of photons into a neural signal. The cell bodies of bipolar cells (B),
horizontal cells (H) and amacrine cells (A) lie in the inner nuclear layer (INL). Cell
bodies of ganglion cells and displaced amacrine cells lie in the ganglion cell layer
(GCL). Synaptic interactions between photoreceptors, bipolar cells and horizontal cells
occur in the outer plexiform layer outer plexiform layer (OPL). Synaptic interactions
between bipolar cells, amacrine cells and ganglion cells occur in the inner plexiform
later (IPL). Ganglion cell axons form the optic nerve that projects to the brain.
Retinal amacrine cells
Retinal ACs are the cells of interest in our lab because they form majority of
synapses in the IPL (Marc and Liu 2000). Therefore, ACs must have an important role
in shaping retinal signals. There are ~40 morphologically different types of ACs in the
vertebrate retina. Different AC morphologies suggest different functions, and
understanding their contribution is essential to understanding how visual information is
conveyed and shaped in the inner retina. AC somas are located within the INL, as well
as some that are displaced to the GCL, and send their processes into the IPL where
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they form reciprocal, serial, and/or lateral synapses with bipolar cells, ganglion cells,
and other ACs. Even though the functions of majority of ACs remain unknown, the
functions of some subtypes have been identified.
Dopaminergic ACs are wide-field (extend their dendrites laterally > 500 µm) and
synthesize dopamine, a neurotransmitter which works in a paracrine manner in the
retina. Under scotopic (low) light, horizontal cells are electrically coupled via gap
junctions, which increases sensitivity to light but decreases visual resolution. As
photopic (bright) light range is reached, dopaminergic ACs release dopamine, which in
turn acts on the dopamine receptor 1 (DR1) on horizontal cells (Nguyen-Legros et al.
1999). The DR1 is a G-protein coupled receptor that activates adenylyl cyclase, which
subsequently activates a cAMP-sensitive protein kinase (Lasater 1987). This pathway
leads to horizontal cell uncoupling, which enhances visual resolution by reducing the
receptive field of bipolar cells (Shen et al. 2003). The light-dependent release of
dopamine also leads to AII AC uncoupling (see below).
AII (A2) ACs (Vaney et al. 1991) are narrow-field (extend their dendrites
vertically), glycinergic cells that serve to integrate signals arising from the rod
photoreceptor pathway into the cone photoreceptor pathway (Demb and Singer 2012).
The rod pathway is thought to have evolved after the cone pathway because rod bipolar
cells “piggyback” onto the cone pathway by synapsing onto AII ACs, which in turn
synapse onto OFF-cone bipolar cells and form gap junctions with ON-cone bipolar cells
(Demb and Singer 2012; Strettoi et al. 1992). AII ACs also form gap junctions with other
AII ACs. This electrical coupling functions to amplify the rod pathway by increasing the
receptive field beyond the dendritic field of AII ACs (Mills and Massey 1995).
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Starburst amacrine cells (SBACs) are direction-selective, wide-field ACs. SBACs
are both GABAergic and cholinergic and function in direction selectivity by differentially
inhibiting direction-selective ganglion cells (Taylor and Smith 2012). SBACs are the only
retinal cell type known to release acetylcholine.
These three types of ACs play an important role in shaping the visual signal that
ganglion cells send to visual regions of the brain. The functions just among these three
types of ACs are very diverse, suggesting that the theme of diverse functions for ACs is
likely to persist as we learn more.
Retinal amacrine cell signaling
Neurons are generally considered to be highly polarized cells that receive
synaptic input from other neurons at their dendrites, transform the synaptic input into
action potentials that propagate down their axon, and then generate synaptic output
from the axonal synaptic terminal (e.g. motor neurons). Many types of ACs, however, do
not have formal axons. Instead, ACs form complex microcircuits within dual function
dendrites: synaptic input is received and synaptic output can be generated within the
same dendrite (Chavez et al. 2010; Grimes et al. 2010; Grimes et al. 2015; Tsukamoto
et al. 2001). AC microcircuits formed by these mixed-use dendrites allow for highlylocalized synaptic signaling in dendrites, which can also have localized Ca2+ elevations
(Euler et al. 2002). AC dendritic Ca2+ elevations are initiated by presynaptic bipolar cell
glutamate release. Activation of AC glutamate receptors alone is sufficient to trigger
GABA release at localized reciprocal synapses (Chavez and Diamond 2008; Chavez et
al. 2006; Grimes et al. 2015). At more lateral AC synapses, action potentials are
involved in GABA release (Chavez et al. 2010; Cook and McReynolds 1998; Cook and
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Werblin 1994; Shields and Lukasiewicz 2003). Voltage-gated L-type Ca2+ channels are
localized at narrow-field AII AC output synapses (Habermann et al. 2003) and mediate
neurotransmitter release in wide-field GABAergic ACs (Vigh and Lasater 2004).
AC intracellular Ca2+ stores can also play a role in synaptic signaling by
enhancing evoked and spontaneous release of GABA through Ca2+-induced Ca2+
release (CICR) via IP3 receptors (IP3Rs) (Warrier et al. 2005) and/or ryanodine
receptors (RyRs) (Chavez et al. 2006). One study, recording from cultured ACs that
express both IP3Rs and RyRs, demonstrated that CICR through IP3Rs, not RyRs,
enhances GABA release (Warrier et al. 2005). However, another study recording from
A17 ACs in rat retinal slices demonstrated that CICR through RyRs, not IP3Rs,
enhanced depolarization-independent, but glutamate-dependent GABA release
(Chavez et al. 2006). It is unclear, however, if IP3R- and RyR-pathways are involved in
Ca2+ signaling in the same AC or if each pathway is specific to certain AC subtypes
(Chavez et al. 2006; Warrier et al. 2005). Any modulation in localized AC Ca2+ signaling
at presynaptic sites will alter their synaptic output, which is important for proper
processing of the visual signal.
Nitric oxide in the retina
Nitric oxide (NO) is a gaseous messenger molecule synthesized by the enzyme
nitric oxide synthase (NOS). The substrate for NOS is L-arginine, and the products are
L-citrulline and NO (Figure 1.2). Two calcium/calmodulin (Ca2+/CaM)-dependent
isoforms of NOS, neuronal NOS (nNOS) and endothelial NOS (eNOS), and one
calcium-independent isoform, inducible NOS (iNOS), have all been shown to be
expressed with variable degree in the vertebrae retina (Donovan et al. 2001; Knowles

5

and Moncada 1994; Miyagi et al. 2002; Piehl et al. 2007). The isoform nNOS is
constitutively expressed in subsets of all cell types in the vertebrate retina, and recently,
the isoform eNOS has been shown to be expressed in horizontal, amacrine and Müller
cells in the chicken retina (Tekmen-Clark and Gleason 2013). There are at least 15
known types of nNOS-positive, NO-producing neurons in the chicken inner retina, 9 of
which are ACs (Cellerino et al. 2000; Fischer and Stell 1999; Wilson et al. 2011).

Figure 1.2. Enzymatic NO production. Using L-arginine, the energy from NADPH, and
oxygen, nitric oxide synthase synthesizes L-citrulline and NO. NO can then activate its
canonical receptor soluble guanylate cyclase (sGC) and increase cGMP production. NO
can also alter protein function by binding to a sulfhydryl group on cysteine residues.
In the intact mouse retina, NO synthesis in the IPL is stimulated by both steady
and flickering light (Blom et al. 2012). Activation of voltage-gated calcium channels
(VGCCS) or Ca2+ permeable NMDA receptors (NMDARs) in ACs that express
nNOS/eNOS will cause a transient rise of intracellular Ca2+, which can activate NOS
and lead to synthesis of NO (Pang et al. 2010). Light-dependent production of NO also
leads to S-nitrosylation (see below) of proteins throughout the retina, which could alter
protein function (Tooker and Vigh 2015). The increase of NO production via light
stimulation suggests that NO has a role in processing the visual signal. A few functions
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for NO have been determined including modulation of dopamine release (Sekaran et al.
2005), uncoupling of horizontal cells (Daniels and Baldridge 2011; DeVries and
Schwartz 1989; Lu and McMahon 1997; Pottek et al. 1997), blocking AII-cone bipolar
coupling (Mills and Massey 1995; Xia and Mills 2004), and modulation of light
responses (Kurenny et al. 1994; Levy et al. 2004; Sato et al. 2011). However, the full
range of NO’s effect on retinal signaling remains unclear.
Regulation of nNOS and eNOS
Although nNOS/eNOS activation is dependent on Ca2+/CaM association,
additional mechanisms regulate nNOS/eNOS activity and subcellular localization. Posttranslational modifications such as phosphorylation, acylation and S-nitrosylation alter
the function of nNOS/eNOS. Depending on the site, phosphorylation of nNOS/eNOS
can either increase or decrease activity (Dimmeler et al. 1999; Michel et al. 1997;
Rameau et al. 2003). Acylation (myristoylation and palmitoylation) attaches eNOS to the
plasmalemmal caveolae membrane (Garcia-Cardena et al. 1996; Shaul 2002).
Depalmitoylation of eNOS is due to prolonged exposure to its substrate, L-arginine, and
is potentiated by Ca2+/CaM (Yeh et al. 1999). Depalmitoylation results in translocation of
eNOS to other intracellular regions; one possible mechanism by which eNOS activity is
regulated (Feron and Balligand 2006; Shaul 2002; Yeh et al. 1999). S-nitrosylation, as
described below, can act as a negative feedback mechanism by inhibiting the function
of NOS.
Protein-protein interactions can also regulate NOS activity. Association with the
caveolae scaffolding protein caveolin reversibly inhibits eNOS (Michel et al. 1997).
Neuronal NOS can be anchored to the post-synaptic density protein-95 (PSD-95), which
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links nNOS to NMDA receptors (Eldred and Blute 2005; Sattler et al. 1999). This can
lead to quick activation of nNOS and NO synthesis when NMDA receptors are
activated. CAPON, an adaptor protein, can regulate nNOS interactions with Dexras1, a
small G protein of the Ras family (Jaffrey et al. 1998). NOSTRIN (eNOS trafficking
inducer protein) is an adaptor protein that regulates internalization of eNOS towards
intracellular compartments (Icking et al. 2005; Zimmermann et al. 2002). NOSIP (nitric
oxide synthase interacting protein) inhibits nNOS production of NO by modifying nNOS
localization and activity (Schleicher et al. 2005). Regulation of NOS activity by
subcellular localization adds another level of complexity to the diverse functions of NO.
Nitric oxide targets
There are several known targets of NO. The most studied target is soluble
guanylate cyclase (sGC), also known as the canonical “NO receptor” (Arnold et al.
1977). Soluble guanylate cyclase activation produces cyclic guanosine monophosphate
(cGMP) and occurs when NO binds to the heme group of sGC. Cyclic GMP is a
secondary messenger molecule that activates a serine/threonine kinase known as
protein kinase G (Poulos 2006).
Nitric oxide can also have direct effects on proteins. S-nitrosylation occurs when
a NO group is covalently attached to a thiol group located on cysteine residues (Figure
1.2). Much like phosphorylation, S-nitrosylation can alter the function of a protein.
Potential targets for S-nitrosylation include ryanodine receptors (Aracena-Parks et al.
2006), G-protein coupled receptors (Estrada et al. 1997), cyclic nucleotide-gated ion
channels (Broillet 2000), potassium channels (Asada et al. 2009; Kawano et al. 2009;
Nunez et al. 2006), and transient receptor potential channels (Shimizu et al. 2014;
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Takahashi et al. 2012; Yoshida et al. 2006). In the retina, light-dependent NO
production leads to S-nitrosylation of more than 300 identified proteins (Tooker and Vigh
2015)
Although work in the Gleason lab has been done on the postsynaptic effects of
NO in ACs (Hoffpauir et al. 2006; Krishnan and Gleason 2015), the NO-synthesizing
enzyme nNOS is located presynaptically at the electron microscopy level, and a
presynaptic role for NO on AC neurotransmitter release had remained uninvestigated.
Thus, I tested the hypothesis that NO can alter the release of GABA from ACs. The
results presented here provide the first direct evidence that NO enhances spontaneous
and evoked Ca2+-dependent GABA release from ACs. In Chapter 2, I explore the
mechanism underlying the NO-dependent enhancement of GABA release from ACs.
My work in this chapter was published in the Journal of Neurophysiology in 2017. In
Chapter 3, I demonstrate that ACs in culture and in the adult retina express TRPC5 a
Ca2+-permeable ion channel, and using a combination of pharmacology and a genetic
knockdown strategy, I demonstrate that TRPC5 is required for the NO-dependent
increase in dendritic Ca2+ and enhancement of GABA release.
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CHAPTER 2
NITRIC OXIDE PROMOTES GABA RELEASE BY ACTIVATING A
VOLTAGE-INDEPENDENT CA2+ INFLUX PATHWAY
IN RETINAL AMACRINE CELLS*
Introduction
Amacrine cells (ACs) are retinal interneurons that shape the visual signal in the
inner retina via activity of their primarily glycinergic and GABAergic synapses. Most
ACs have mixed-use dendrites because they are sites of both synaptic input and
synaptic output. ACs form complex microcircuits by making reciprocal, lateral and serial
inhibitory synapses with bipolar cells, ganglion cells and other ACs (Chavez et al. 2010;
Grimes et al. 2010; Grimes et al. 2015; Tsukamoto et al. 2001). These microcircuits are
localized to AC dendrites, which can also have localized Ca2+ elevations (Euler et al.
2002).
Nitric oxide synthase (NOS) is a nitric oxide (NO) synthesizing enzyme that has
two Ca2+-sensitive isoforms: endothelial NOS (eNOS) and neuronal NOS (nNOS). Both
enzymes have been localized to ACs as well as other retinal cell types (Fischer and
Stell 1999; Haverkamp et al. 2000; Kim et al. 1999; Kim et al. 2000; Pang et al. 2010;
Tekmen-Clark and Gleason 2013). Neuronal NOS has also been localized to AC
presynaptic terminals in the inner turtle retina (Cao and Eldred 2001), suggesting that
localized NO synthesis can affect neurotransmitter release.

*This chapter previously appeared as “Nitric oxide promotes GABA release by activating
a voltage-independent Ca2+ influx pathway in retinal amacrine cells” J. Wesley Maddox
and Evanna Gleason, Journal of Neurophysiology. Published 1 March 2017 Vol. 117 no.
3, 1185-1199. DOI: 10.1152/jn.00803.2016. It is reprinted by permission of American
Physiological Society. See Appendix for letter granting permission.
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The major signaling mechanisms for NO are through the cGMP pathway via
activation of the canonical NO receptor, soluble guanylate cyclase, and through the
direct chemical modification of proteins via S-nitrosylation. The light-dependent
operation of both pathways appears to be widespread in the retina (Blom et al. 2012;
Tooker and Vigh 2015). Although NO is typically viewed as diffusible, NO imaging has
demonstrated that NO is largely confined to cellular boundaries in multiple retina cell
types including ACs (Eldred and Blute 2005; Tekmen-Clark and Gleason 2013). This
implies that NO-dependent mechanisms can be localized to NO-producing cells and to
their immediate synaptic partners.
The functions of NO in the retina are not fully known, but multiple sites of NO
action have been identified. NO production is stimulated under photopic illumination
and is known to be involved in light adaptation. For example, NO decouples horizontal
cells (HCs) from other HCs (DeVries and Schwartz 1989; Miyachi et al. 1990) and
decouples ON bipolar cells from A2 ACs (Mills and Massey 1995). NO can also affect
the ON and OFF pathways. In retinal ganglion cells, NO reduces both ON and OFF
light responses with the OFF responses being the most sensitive to NO (Wang et al.
2003). The mechanism underlying this inhibition of the pathway was not fully worked
out, but the results pointed to an effect on neurons presynaptic to ganglion cells, most
likely ACs. Thus, AC synaptic function may be regulated by NO.
To test the hypothesis that NO can alter synaptic output from ACs, we employed
whole-cell current recordings and intracellular Ca2+ imaging in cultured chick ACs. We
found that the NO donor SNAP increased both spontaneous and evoked GABAergic
neurotransmission due to a NO-dependent increase of cytosolic Ca2+. We find that a
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likely TRPC-mediated Ca2+ influx is required, however, Ca2+ release from stores is not
required. These data suggest that NO activates a presynaptic Ca2+ influx pathway that
enhances GABAergic output from AC synapses in the retina.
Methods
Amacrine cell cultures
The use of chick embryos to prepare retinal cultures was determined to be
exempt by the LSU Institutional Animal Care and Use Committee. Eight-day white
leghorn (Gallus gallus) chick embryo retinas were removed from the eyecup and
dissected free of the retinal pigment epithelium. Retinas were initially dissociated in
Ca2+- and Mg2+-free Hank’s solution (Life Technologies, Grand Island, NY). The tissue
was centrifuged (950 × g), and the supernatant replaced with 0.125% trypsin (SigmaAldrich, St. Louis, MO). The pellet was resuspended and incubated at 37 °C/5% CO2
for 30 min. After incubation and centrifugation (1,900 × g), the supernatant was
replaced with Dulbecco’s Modified Eagle Medium (DMEM, Life Technologies)
supplemented with 5% fetal bovine serum (Sigma-Aldrich), penicillin (100 U/mL),
streptomycin (100 µg/mL) and glutamine (2 mM) (Life Technologies). Cells were plated
at a density of 2.5 × 105 cells/35 mm dish that were pretreated with 0.01% poly-DLornithine hydrobromide (Sigma Aldrich). Cultures were fed every other day after initial
plating by replacing half of the media with Neurobasal medium supplemented with 1%
B-27, penicillin (100 U/mL), streptomycin (100 µg/mL) and glutamine (2 mM) (Life
Technologies). Experiments were performed on ACs that had been in culture for 8-13
days (embryonic equivalent days 16 to 21). Over this time in culture, AC-to-AC
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GABAergic synapses are functional. ACs were identified on morphological criteria
(Gleason et al. 1993).
Electrophysiology
Whole-cell voltage clamp recordings were performed using Axopatch 1D
amplifier, Digidata 1322A data-acquisition board, and Clampex 10.0 (Molecular
Devices, Sunnyvale, CA). Patch pipette electrodes with a tip resistance between 5-10
MΩ for ruptured-patch recordings or 3-5 MΩ for perforated-patch recordings were pulled
from thick-walled borosilicate glass (1.5 mm O.D., 0.86 mm I.D.) using a P-97
Flaming/Brown Puller (Sutter Instruments, Novato, CA). A reference Ag/AgCl electrode
pellet was placed in 3 M KCl and connected to the culture dish with a 3 M KCl agarose
bridge. Recordings were performed at room temperature (22-24°C). A pressurized
perfusion system (AutoMate Scientific, Berkeley, CA) was used to deliver external
solutions at a flow rate of 1 mL/min. Most recordings were performed on postsynaptic
ACs whose processes were in contact with unclamped presynaptic ACs and that had
spontaneous postsynaptic currents (sPSCs). Variability of basal sPSC frequency
depended on cell culture density. Denser cultures had higher basal sPSC frequency,
possibly due to more synaptic sites. Cells that did not have basal sPSCs also did not
respond to the NO donor S-nitroso-N-acetyl-D,L-penicillamine (SNAP; Enzo,
Farmingdale, NY) and were excluded from the analysis. Autaptic recordings were made
from ACs that were not in contact with other ACs to eliminate the possibility that input
was coming from unclamped cells.

18

Solutions
All reagents were purchased from Sigma-Aldrich unless otherwise stated.
Tetraethylammonium (TEA)-Cl external solution (in mM): NaCl (117), KCl (5.3), TEA-Cl
(20), CaCl2 (3), MgCl2 (0.41), glucose (5.6), HEPES (10), pH 7.4. LiCl (117) replaced
NaCl in evoked autaptic experiments to block the Na+/Ca2+ exchanger current that can
contaminate the autaptic currents at the end of the voltage step. Rupture-patch high Clinternal solution (in mM): CsCl (110), MgCl2 (2), CaCl2 (0.1), EGTA (1), HEPES (10),
NaCl2 (1), ATP-2Na+ (3), ATP- 2K+ (1), GTP (2), phosphocreatine (20), creatine
phosphokinase (50 U/mL), pH 7.4. Perforated-patch high Cl- internal solution (in mM):
CsCl (145), MgCl2 (2), CaCl2 (0.1), EGTA (1), HEPES (10), NaCl (1), pH 7.4,
amphotericin B (200 μg/mL). Perforated-patch normal internal solution (in mM): CsAcetate (135), MgCl2 (2), CaCl2 (0.1), EGTA (1), HEPES (10), NaCl (1), pH 7,4,
Amphotericin B (200 μg/mL). Typical reversal potential for Cl- (ECl-) in cultured ACs is
~-80 mV to -60 mV, however, these high Cl- internal solutions increase the reversal
potential of Cl- to 0 mV, increasing the driving force on Cl- and improving the resolution
of quantal events. High internal Cl- also blocks the NO-dependent release of Cl(Hoffpauir et al. 2006). While we have previously shown that the concentration of SNAP
used here (500 μM) does not elicit Cl- release (Hoffpauir et al. 2006), this internal
solution further ensures that the NO-dependent release of Cl- will not confound our
results. For imaging experiments, the following external solutions were used: Normal
external solution (in mM): NaCl (137), KCl (5.37), CaCl2 (3), MgCl2 (0.41), glucose (5.6),
HEPES (3.02), pH 7.4. Zero Ca2+ external solution (in mM): NaCl (141.5), KCl (5.37),
MgCl2 (0.41), glucose (5.6), HEPES (3.02), pH 7.4.
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Reagents
The NO donor SNAP (500 μM; Enzo), the NO scavenger 2-[4-carboxyphenyl]4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide (CPTIO, 10 μM, Enzo), bicuculline (10
μM), and TTX (300 nM; Abcam, Cambridge, MA) were dissolved directly into the
external solution. 1,2-Bis(2-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid tetrakis
(acetoxymethyl ester) (BAPTA-AM, 10 μM, Life Technologies) was prepared as a 10
mM stock in DMSO. The stock was diluted into Hank’s Balanced Salt Solution with
NaHCO3 (HBSS), briefly vortexed and sonicated for 30 s. Cells were incubated with
BAPTA-AM at 37 ºC/5% CO2 for 45 minutes prior to recording. 1H[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ, 2 μM; Tocris, Bristol, UK), 2Aminoethoxydiphenylborane (2-APB, 20 μM; Tocris), 1-[2-(4-Methoxyphenyl)-2-[3-(4methoxyphenyl)propoxy]ethyl-1H-imidazole hydrochloride (SKF 96365, 30 μM, Tocris),
N-Ethylmaleimide (NEM, 300 μM; Sigma), 1,4-Dihydro-2,6-dimethyl-4-(2-nitrophenyl)3,5-pyridinedicarboxylic acid dimethyl ester (nifedipine, 20 μM; Tocris), 6-Cyano-7nitroquinoxaline-2,3-dione (CNQX, 50 μM), and 1-[(4-Chlorophenyl)methyl]-2-(1pyrrolidinylmethyl)-1H-benzimidazole hydrochloride (clemizole, 10 μM; Tocris) were
prepared as 1000X stocks in DMSO and diluted to 1X in external solution. D-(-)-2Amino-5-phosphonopentanoic acid (D-AP5, 10 μM; Tocris) was prepared as a 10 mM
stock and diluted in external solution. The sarco/endoplasmic reticulum Ca2+ ATPase
(SERCA) pump inhibitor thapsigargin (TG; 2 µM; Enzo) was prepared as a 2 mM stock
in DMSO and added directly to the culture media. Cells were incubated with TG at 37
ºC/5% CO2 for 1 hr. The external solution pH was readjusted to 7.4 after the addition of
reagents.
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Calcium imaging
The fluorescent Ca2+ indicator Oregon Green 488 BAPTA-1, AM (OGB, 2 µM,
Life Technologies) was prepared as a 2mM stock in DMSO. OGB stock and Pluronic F127 (2.5% w/v in DMSO, Life Technologies) were mixed in a 1:1 ratio and sonicated. 2
µL of the OGB/Pluronic mixture was diluted in 1 mL of Hank’s buffered salt solution
(HBSS) then briefly vortexed and sonicated for 30 s. Cells were incubated with the
HBSS/OGB/Pluronic mixture for 1 hr at room temperature (22-24°C).
HBSS/OGB/Pluronic mixture was replaced with normal external solution. Images were
taken every 500 ms (200 ms exposure), 3 s (400 ms exposure), or 6 s (200 ms
exposure). To obtain data relevant to synaptic function, regions of interest (ROIs) were
chosen at sites of contact between processes. Images were captured on an inverted
Olympus IX70 microscope (Tokyo, Japan) fitted with a SensiCam QE (Cooke, Kelheim,
Germany). Data were collected and analyzed using Slidebook software (Intelligent
Imaging Innovations, Denver, CO). In all Ca2+ imaging experiments, the control
fluorescence mean was calculated by using the average of the last 10 ROI time points
before switching solutions, and the fluorescence means after switching solutions were
calculated by using the 10 ROI time points from the middle of each solution application.
The control and different solution fluorescence means were used to calculate percent
change in fluorescence.
Data analysis
For sPSC electrophysiology experiments, Mini Analysis Program (Synaptosoft,
Inc, Fort Lee, NJ) was used to detect and analyze sPSCs. Quantal event kinetics were
analyzed using data from cells that were only exposed to SNAP. Multiquantal events
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were removed from analysis by determining the mean and SD of the rise time of quantal
events from control data where multiquantal events are extremely rare. Quanta with a
rise time longer than 3.7 ms (mean rise time plus one SD) were excluded from the
analysis. Mean amplitudes (pA), mean rise times (ms) and mean decay times (ms) were
determined from each of the 9 recorded cells during control (254 total events) and
application of SNAP (319 total events, 489 multiquantal events removed). Mean
amplitude, mean rise time and mean decay time from each cell were used for statistical
analysis. Charge transfer integration and Ca2+ current leak subtraction was performed
using OriginPro (OriginLab, Northampton, MA). Charge transfer was calculated by
integrating the area under the post-depolarization autaptic current waveform. The
charge transfer integration (pA*s) was then calculated and reported as pC. After linear
leak subtraction, activation voltage of voltage-gated Ca2+ channels was measured at the
point the Ca2+ current reached 5% of the maximum current amplitude. In autaptic and
voltage-ramp experiments, perforated-patch configuration using amphotericin B (Sigma)
was used to maintain the native presynaptic environment as much as possible during
prolonged recording times. Because amphotericin B introduces an unknown liquid
junction potential, voltages were left uncorrected. Statistics were performed using
GraphPad Prisim 6 (GraphPad Software, La Jolla, CA). Repeated Measures-ANOVA
with Fisher’s Least Significant Difference (LSD) post hoc analysis was performed on all
data unless otherwise indicated. Data are reported as mean ± SE.
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Results
SNAP increases sPSC frequency
To determine whether NO affects spontaneous neurotransmitter release, ACs
bearing processes in contact with other (unclamped) ACs were voltage clamped at -70
mV in TEA-Cl external solution. For spontaneous postsynaptic current (sPSCs)
recordings, high-Cl- internal solution was used to increase the driving force on Cl- (at -70
mV). Under control conditions, sPSCs corresponding to quantal events were observed
ranging in frequency from 1.4 to 77.6 events/30 s. When SNAP (500 μM) and the NO
scavenger CPTIO (10 μM) were co-applied, no change in sPSC frequency was
observed (control, 9.8 ± 3/30 s, SNAP/CPTIO, 10.7 ± 3/30 s, P = 0.5, n = 8, Figure 2.1).
When CPITO was removed and only SNAP was present, however, there was a 108%
increase in sPSC frequency (SNAP/CPTIO, 10.7 ± 2.7/30 s, SNAP, 22.3 ± 5.2/30 s, P =
0.03, n = 8, Figure 2.1). NO did not affect the quantal event amplitude (control, 11.6 ±
0.8 pA, SNAP, 11.3 ± 1.2 pA, P = 0.63, n = 9 cells, paired t-test), rise time (control, 2.3 ±
0.1 ms, SNAP, 2.5 ± 0.1 ms, P = 0.12, n = 9 cells, paired t-test), or decay time (control,
9.55 ± 1.1 ms, SNAP, 9.9 ± 1.2 ms, P = 0.86, n = 9 cells, paired t-test). Thus, these
data indicate that NO, rather than the donor molecule or NO metabolites, increased
presynaptic spontaneous vesicle fusion and neurotransmitter release but did not affect
the postsynaptic receptors.
NO-dependent increase of sPSC frequency does not require soluble guanylyl cyclase
(sGC) activity
The canonical receptor for NO is sGC, and NO-activated sGC increases the
production of the secondary messenger cGMP. To determine if NO-dependent
activation of sGC and cGMP signaling was involved in the increase of sPSC frequency,
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Figure 2.1. NO increases frequency of spontaneous postsynaptic currents (sPSCs). A:
recording from a representative postsynaptic AC voltage clamped at -70 mV and
synaptically connected with other unclamped ACs. Co-application of the NO donor SNAP
(500 µM) and the NO scavenger CPTIO (10 µM) had no effect on the sPSC frequency.
After removal of CPTIO, a significant increase sPSC frequency was observed.
*Multiquantal events. B: quantified mean event frequency of sPSCs/30 s SE; n = 8. **P <
0.01 (repeated measures-ANOVA).
cells were pre-incubated with the sGC inhibitor ODQ (2 μM) for 12 minutes prior to
recording, and ODQ remained throughout the recording. Even in the presence of ODQ,
SNAP caused a 173% increase in sPSC frequency (ODQ, 20.1 ± 4.5/30 s, ODQ/SNAP,
54.9 ± 15.0/30 s, P = 0.03, n = 12, Figure 2.2). Acute application of ODQ alone did not
alter sPSC frequency (control, 6.6 ± 3.19/30 s, ODQ, 5.25 ± 2.8/30s, P = 0.06, n = 4,
paired t-test). These data suggest that sGC does not mediate the NO-dependent
increase in sPSC frequency.
Because activation of the canonical NO receptor sGC is not required for the
increase in sPSC frequency, we investigated the role of another NO signaling pathway,
S-nitrosylation that occurs when NO reacts with a cysteine residue thiol group to form a
S-nitrosothiol. S-nitrosylation posttranslational protein modification is similar to
phosphorylation in that it can alter the function of the targeted protein. N-ethylmaleimide

24

Figure 2.2. NO-dependent increase of sPSCs does not require soluble guanylate cyclase
(sGC) activity. A: Recording from a representative AC held at -70 mV. Cells were
exposed to the sGC inhibitor ODQ (2 µM) for at least 12 minutes prior to and throughout
the recordings. SNAP increased the frequency of sPSCs in the presence of ODQ. B:
Quantified mean event frequency of sPSCs/30 s ± SE, n = 12. *P < 0.05 (paired t-test).
(NEM), a known inhibitor of S-nitrosylation, was used to investigate if S-nitrosylation
was involved in the NO-dependent increase in sPSC frequency. NEM (300 µM),
however, caused an increase in sPSC frequency from baseline by 411% (control, 24.2 ±
15.26/30 s, NEM, 123.5 ± 26.78/30 s, P = 0.007, n = 7, paired t-test). Unfortunately,
NEM has multiple targets including presynaptic proteins (Clary et al. 1990; Peters et al.
1990; Rothman 1996) and has been shown to increase GABAergic spontaneous
neurotransmitter release (Kirmse and Kirischuk 2006; Knight et al. 2004) and activate
some Ca2+ channels (Bindoli and Fleischer 1983; Graham et al. 2010; Pan et al. 2011).
These results precluded further experiments using NEM in this study.
NO-increases GABAergic sPSC frequency
Cultured ACs used in the present study have been demonstrated to be
GABAergic (Gleason et al. 1993). However, to confirm that NO is promoting the release
of GABA rather than an additional neurotransmitter, the ionotropic GABA receptor
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antagonist bicuculline (10 μM) was added to the extracellular solution during the
application of SNAP. SNAP caused a 190% increase in sPSC frequency (control, 7.6 ±
2.0/30 s to SNAP, 22.1 ± 5.7/30 s, P = 0.02; n = 9, Figure 2.3A-B). However,
bicuculline caused a 99% reduction in NO-dependent sPSC frequency (SNAP, 22.1 ±
5.7/30 s, SNAP/bicuculline, 0.3 ± 0.1/30 s, P = 0.003, n = 9, Figure 2.3A-B). These data
indicate that NO increased GABAergic sPSCs due to increased presynaptic vesicle
fusion and GABA release, but not due to the release of any other neurotransmitter.
Previous work from our lab demonstrated a small (~15%) NO-dependent enhancement
of whole-cell GABAA receptor currents, apparently due to an alteration in channel
function (Hoffpauir et al. 2006). Here, we see no effect of NO on sPSC current
amplitude, suggesting that synaptic and extra-synaptic receptors may be differentially
regulated.
NO-dependent increase of sPSC frequency is not action potential-dependent
Some ACs are known to fire action potentials (Cook et al. 1998; Heflin and Cook
2007; Watanabe et al. 2003). For the experiments recording sPSCs (Figures. 2.1-3A),
presynaptic ACs were unclamped, which allows their membrane potentials to fluctuate
and possibly produce action potentials. To determine whether the NO-dependent
increase of GABA release was due to presynaptic action potentials in response to NO,
the voltage-gated Na+ channel blocker tetrodotoxin (300 nM, TTX) was included in the
TEA-Cl external solution. In the presence of TTX, SNAP still elicited a 202% increase in
sPSC frequency (TTX, 7.3 ± 2.0/30 s, TTX/SNAP, 22.1 ± 5.7/30 s, P = 0.03, n = 5,
paired t-test, Figure 2.3C-D). This indicates that sPSC frequency was increased by a
NO-dependent mechanism that does not require action potentials.
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Figure 2.3. NO-induced increase in GABAergic sPSC frequency does not require action
potentials. A: Recording from a representative postsynaptic AC held at -70 mV.
Application of the NO donor SNAP increased the frequency of sPSCs. Addition of the
GABAA receptor antagonist bicuculline abolished the NO-dependent increase of sPSCs,
indicating that these are GABAergic sPSCs. B: Quantified mean event frequency of
sPSCs/30 s ± SE, n = 9. *P < 0.05, **P < 0.01 (repeated measures-ANOVA). C: Voltage
clamp recording from a representative postsynaptic AC held at -70 mV. SNAP increased
the frequency of sPSCs in the presence of the voltage-gated Na+ channel blocker TTX
(300 nM). D: Quantified mean event frequency of sPSCs/30 s ± SE, n = 5. *P < 0.05
(paired t-test).
Vesicle fusion and neurotransmitter release depends on the local presynaptic
Ca2+ concentration. To determine whether NO affects cytosolic Ca2+, cytosolic Ca2+
levels were monitored using the fluorescent Ca2+ indicator Oregon Green 488 BAPTA-1
(OGB, 2 μM). Data were collected from regions of neuronal process contacts,
potentially synaptic sites. Co-application of the NO scavenger CPTIO and SNAP did
not significantly alter intracellular Ca2+ (P = 0.17, n = 57, Figure 2.4A-B). After removal
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Figure 2.4. NO increases intracellular Ca2+. A: Calcium imaging of AC processes loaded
with Oregon Green BAPTA-1 488, AM, revealed that NO caused an increase of
intracellular Ca2+ at potential synaptic sites. When the NO donor SNAP (500 μM) and
NO scavenger CPTIO (10 μM) were co-applied, there was no significant increase in
intracellular Ca2+ (P > 0.15). Removal of CPTIO was followed by a significant increase in
cytosolic Ca2+. Note that mean fluorescence in A is larger because data were collected
with longer exposure times (400 ms) than all other data (200 ms). B: Quantified mean
peak fluorescence ± SE in (A), n = 57. ****P < 0.0001 (repeated measures-ANOVA). C:
Intracellular Ca2+ is reduced when extracellular Ca2+ is removed (0 Ca2+ext) even in the
presence of SNAP. D: Quantified mean peak fluorescence ± SE in (C) showing that
SNAP caused a significant increase in fluorescence and that removing extracellular Ca2+
(0 Ca2+ext) significantly reduced the fluorescence, n = 35. ****P < 0.0001 (repeated
measures-ANOVA). Fluorescence over time data are plotted as mean fluorescence ±
SE.
of CPTIO, however, there was a 32% increase in intracellular Ca2+ (CPTIO/SNAP,
26.7± 1.2 AU, SNAP, 35.3 ± 1.6 AU, p < 0.0001, n = 57, Figure 2.4A-B). Additionally,
there was an 11% reduction in cytosolic Ca2+ when external Ca2+ was removed during
the SNAP application, (SNAP, 7.9 ± 0.5 AU, SNAP/0 Ca2+, 7.0 ± 0.4 AU, p < 0.0001, n =
35, Figure 2.4C-D). These results indicated that NO, rather than the donor molecule or
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NO metabolites, increased intracellular Ca2+ via an extracellular Ca2+-dependent
mechanism.
The role of Ca2+
Having established that NO can produce Ca2+ elevations in ACs, we asked
whether the Ca2+ elevations were driving the NO-dependent increase in sPSCs.
BAPTA-AM (10 µM), a cell-permeant fast Ca2+ chelator, was loaded into the cells prior
to recordings. In BAPTA-containing cells, sPSC frequency in the recorded cell was not
enhanced by SNAP (control, 5.9 ± 1.1/30 s, SNAP, 6.4 ± 1.1/30 s, P = 0.62, n = 12,
paired t-test, Figure 2.5B-C). In cells that did not have BAPTA, however, SNAP caused
a 172% increase in sPSC frequency (control, 9.2 ± 1.3/30 s, SNAP, 25.0 ± 2.7/30 s, P =
0.0002, n = 12, paired t-test, Figure 2.5A-C). These results suggest that the NOdependent increase in intracellular Ca2+ is responsible for the NO-dependent increase
in sPSC frequency.
To determine if Ca2+ influx, specifically, is involved in the NO-dependent increase
of sPSCs, extracellular Ca2+ was removed during the application of SNAP. Prior to Ca2+
removal, SNAP caused a 61% increase in sPSC frequency (control, 19.4 ± 8.8/30 s,
SNAP, 31.2 ± 12.7/30 s, P = 0.03, n = 8, Figure 2.5D-E). When extracellular Ca2+ was
removed during SNAP application, there was a 62% reduction in sPSC frequency
(SNAP, 31.2 ± 12.7/30 s, SNAP/0 Ca2+, 11.9 ± 7.1/30 s, P = 0.02, n = 8, Figure 2.5D-E).
These results indicate that Ca2+ influx is required for the NO-dependent increase of
sPSC frequency.
Ca2+ stores can play a role in vesicle fusion and GABA release in ACs (Chavez
et al. 2010; Chavez et al. 2006; Ke et al. 2010; Warrier et al. 2005). The contribution of
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Figure 2.5. The NO-dependent increase of sPSC frequency is dependent upon cytosolic
Ca2+ elevations. A,B: Representative recordings from postsynaptic ACs voltage clamped
at -70 mV. A: The NO donor SNAP was able to increase sPSC frequency under control
conditions (No BAPTA). B: In BAPTA loaded ACs (+ BAPTA), however, SNAP did not
increase sPSC frequency. C: Quantified mean event frequency/30 s ± SE. Cells
containing BAPTA did not experience an NO-dependent increase in sPSC frequency (n
= 12 for each group). ***P < 0.001 (paired t-test). D: Recording from a representative
AC held at -70 mV. After the removal of extracellular Ca2+ (0 Ca2+ext), NO is no longer
effective in increasing the frequency of sPSCs. E: Quantified mean frequency of
sPSCs/30 s ± SE, n = 8. *P < 0.05 (repeated measures-ANOVA).
stores to the NO-dependent increase in cytosolic Ca2+ was investigated in OGB-loaded
ACs that were pre-incubated with the SERCA pump inhibitor thapsigargin (TG, 2µM, 1
hr). The effectiveness of this treatment in emptying the Ca2+ store was evaluated by
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perfusing caffeine (20 mM) to release store Ca2+. For control cells in zero Ca2+ external
solution (0 Ca2+ext), caffeine reliably produced rapid increases in cytosolic Ca2+ at
contact points between processes (0 Ca2+ext, 12.33 ± 1.21 AU, 0 Ca2+ext and caffeine,
13.52 ± 1.14 AU, P = 0.004, n = 25, Figure 2.6A,C). However, cells pretreated with TG
did not produce caffeine-dependent Ca2+ elevations, indicating depletion of the Ca2+
store (Figure 2.6B,D). Using this same TG pretreatment protocol, the effect of SNAP on
cytosolic Ca2+ was examined. Under normal external Ca2+ conditions, SNAP elicited a
15% and 9% Ca2+ elevation in both control (control, 6.2 ± 0.4 AU, SNAP, 7.1 ± 0.5 AU, p
< 0.0001, n = 50, paired t-test, Figure 2.6E,G) and TG-treated (control, 9.4 ± 1.3 AU,
SNAP, 10.2 ± 1.2 AU, p < 0.0001, n = 17, paired t-test, Figure 2.6F,H) cells,
respectively. TG-treated cells produced no NO-dependent Ca2+ elevations in the
absence of extracellular Ca2+ (0 Ca2+, 6.9 ± 0.3 AU, 0 Ca2+/SNAP, 6.8 ± 0.3 AU, P =
0.06, n = 107, Figure 2.6I,J). These data show that under these conditions NO elicits
Ca2+ elevations by activating a Ca2+ influx pathway exclusively.
To confirm that Ca2+ stores do not play a role in the NO-dependent increase of
sPSCs, voltage clamp recordings were made from ACs pre-incubated in TG. SNAP still
caused a 65% and 171% increase in sPSC frequency in TG-treated (control, 18.3 ±
5.3/30 s, SNAP, 30.2 ± 6.1/30 s, P = 0.003, n = 8, paired t-test, Figure 2.7B-C) and in
control (control, 10.1 ± 4.1/30 s, SNAP, 27.4 ± 8.3/30 s, P = 0.034, n = 4, paired t-test,
Figure 2.7A,C) cells, respectively. These results confirm that NO increases GABAergic
sPSC frequency by activating a plasma membrane Ca2+ influx pathway that is
independent of Ca2+ release from stores.
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Figure 2.6. NO-dependent increase of intracellular Ca2+ is independent of intracellular
stores. A: In the absence of extracellular Ca2+ (0 Ca2+ext), caffeine (20 mM) produced a
rapid and transient increase in intracellular Ca2+ when thapsigargin (TG) was not present.
B: For cells pre-incubated in TG (2 μM, 1 hr), no caffeine-dependent store release was
observed. C,D: Quantified mean fluorescence ± SE in A (n = 25) and B (n = 37),
respectively. E, F: The NO donor SNAP produced an increase in intracellular Ca2+ in
both control and thapsigargin-treated AC processes. G,H: Quantified mean fluorescence
± SE in E (n = 50) and F (n = 107), respectively. I: The NO donor SNAP does not increase
intracellular Ca2+ in the presence of TG and the absence of extracellular Ca2+. J:
Quantified mean fluorescence ± SE in I (n = 107). Images were taken every 500 ms in
A-B, and every 6 s in E-F, I. *P < 0.05, ***P < 0.001, ****P < 0.0001, nsP > 0.57 (repeated
measures-ANOVA). Fluorescence over time data are plotted as mean fluorescence ±
SE.
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Figure 2.7. NO-dependent increase of sPSC frequency is independent of Ca2+ stores.
A,B: Representative recordings from postsynaptic amacrine ACs held at -70 mV without
(A) or with (B) pre-incubation with TG (2 µM, 1 hr). The NO-dependent increase of sPSC
frequency persisted in the presence of TG. C: Quantified mean event frequency/30 s ±
SE. Addition of SNAP increased sPSCs in cells with intact Ca2+ stores (No TG, n = 4)
and after Ca2+ store depletion (+TG, n = 8). *P < 0.05, **P < 0.01 (paired t-tests).
NO increases evoked GABAergic autaptic transmission
In the retina, ACs receive excitatory signals from bipolar cells. Depolarization of
ACs leads to evoked neurotransmitter release onto postsynaptic cells, which can be
bipolar cells, ganglion cells or other ACs. To determine the role of NO in evoked
neurotransmitter release, perforated patch whole-cell recordings were performed on
isolated ACs making autapses. Cells were depolarized from -70 mV to -20 mV for 50
ms to activate voltage-gated Ca2+ channels (VGCCs) and subsequently cause vesicle
fusion and neurotransmitter release. The autaptic currents persisting after the voltage
step were quantified. SNAP caused a 51% increase in charge transfer (control, 177.0 ±
47.6 pC, SNAP, 268.1 ± 59.7 pC, P = 0.03, n = 6, Figure 2.8A-B). Bicuculline blocked
the NO-dependent increase of the charge transfer (bicuculline, 48.2 ± 13.4 pC,
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bicuculline/SNAP, 53.1 ± 16.3 pC, P = 0.32, n = 5, Figure 2.8C-D). Note that the
apparent SNAP-dependent change in the Ca2+ current amplitude during the voltagestep is due to the contamination from inward GABA-gated current (Figure 2.8A), an
effect that is absent in the presence of bicuculline (Figure 2.8C). The sPSC frequency
was also elevated during the SNAP application (Figure 2.8A inset). These data suggest
that NO increases evoked GABAergic neurotransmission, possibly due to additive
effects of two Ca2+ influx pathways being activated (NO-dependent Ca2+ influx and
voltage-dependent Ca2+ influx) simultaneously.
The effect of NO on sPSCs does not involve L-type VGCCs, AMPARs or NMDARs
L-type VGCCs have been demonstrated to mediate neurotransmitter release
between these cultured ACs (Gleason et al. 1993) and other AC synapses in the retina
(Habermann et al. 2003; Vigh and Lasater 2004). It has also been demonstrated that
NO can activate retinal ganglion cell Ca2+ channels (Hirooka et al. 2000) and augment
neuronal L-type Ca2+ currents (Tozer et al. 2012). To determine if NO influences the
voltage-gated Ca2+ current or activation voltage, voltage ramps from -90 mV to +50 mV
were delivered in the presence of TTX (300 nM) and bicuculline (10 μM) to isolate the
Ca2+ current. In these experiments, perforated-patch normal internal solution and TEACl external solution were used. Addition of SNAP did not change the Ca2+ current
amplitude (control, -268.9 ± 45.1 pA, SNAP, -261.2 ± 43.8 pA, P = 0.45, n = 9, Figure
2.9A) or the Ca2+ channel activation voltage (control, -45.36 ± 1.1 mV, SNAP, -45.13 ±
0.73 mV, P = 0.69, n = 9). Additionally, the L-type VGCC inhibitor nifedipine (20 µM) did
not prevent the NO-dependent increase in sPSC frequency (nifedipine, 20.40 ± 4.2/30
s, nifedipine/SNAP, 37.65 ± 6.07/30 s, P = 0.028, n = 5, Figure 2.9B-C). The NO-
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Figure 2.8. NO increases evoked autaptic GABAergic postsynaptic currents. A:
Recording from a representative AC depolarized from -70 mV to -20 mV for 50 ms.
Evoked autaptic currents were increased after the addition of the NO donor SNAP. Inset:
sPSC frequency was elevated between depolarizations during the application of SNAP.
B: Quantified mean charge transfer ± SE, n = 6. *P < 0.05 (paired t-test). C: Recording
from a representative AC depolarized from -70 mV to -20 mV for 50 ms. Addition of the
GABAA receptor antagonist bicuculline blocked the NO-dependent increase of charge
transfer. D: Quantified mean charge transfer ± SE. The NO donor SNAP did not
significantly alter the evoked autaptic currents in the presence of bicuculline, n = 5. P >
0.3, (paired t-test).
dependent increase in sPSC frequency remained unchanged after removal of nifedipine
and leaving only SNAP in the bath (nifedipine/SNAP, 37.65 ± 6.07/30 s, SNAP, 40.3 ±
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8.98/30 s, P = 0.78, n = 5, Figure 2.9B-C). These results demonstrate that L-type
VGCCs are not involved. The possibility that NO could activate AMPA and/or NMDA
glutamate receptors (AMPARs and NMDARs) was investigated using Ca2+ imaging.
The AMPAR and NMDAR antagonists CNQX (50 µM) and D-AP5 (10 µM), respectively,
were applied before and during the application of SNAP. While AMPRs and NMDARs
were blocked, NO increased intracellular Ca2+ by 10.8% (D-AP5/CNQX, 8.1 ± 0.3 A.U.,
D-AP5/CNQX and SNAP, 8.9 ± 0.4 A.U., n = 152 ROIs, p < 0.0001, Figure 2.9D).
When D-AP5 and CNQX were removed, intracellular Ca2+ remained elevated (DAP5/CNQX and SNAP, 8.9 ± 0.4 A.U., SNAP, 9.1 ± 0.4 A.U., n = 152 ROIs, P = 0.1,
Figure 2.9D). These results show that NO does not activate L-type VGCCs, AMPARs
or NMDARs. Therefore, NO must be activating another plasma membrane Ca2+ influx
pathway to admit extracellular Ca2+ presynaptically and to increase sPSC frequency.
Clemizole blocks the NO-dependent increase in sPSC frequency and intracellular Ca2+
Previous work in our lab demonstrated that these amacrine cells contain mRNA
for TRPC subunits 1, 3, 4, 5, 6, and 7 (Crousillac et al. 2003), and TRPC channels can
be activated via S-nitrosylation (Yoshida et al. 2006). To explore the possible role of
TRPC channels in the NO-dependent increase in sPSC frequency, we used two
traditional TRPC inhibitors, 2-APB and SKF 96365. These inhibitors, however, have
multiple documented effects on other ion channels, some of which conduct Ca2+
(DeHaven et al. 2008; Hong et al. 1994; Hotta et al. 2005; Leung et al. 1996; Merritt et
al. 1990; Prakriya and Lewis 2001; Singh et al. 2010; Usmani et al. 2010; Wang 2003).
Bath perfusion of 2-APB (20 µM) alone increased sPSC frequency from baseline by
108% (control, 52 ± 7.5/30 s, 2-APB, 107.9 ± 15.3/30 s, P = 0.01, n = 10, paired t-test),
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Figure 2.9. L-type voltage-gated Ca2+ channels (VGCCs), AMPARs or NMDARs are not
required for the NO-dependent Ca2+ influx. A: Voltage clamp recording from a
representative AC ramped from -90 mV to 50 mV. The NO donor SNAP (500 µM) did not
affect the activation voltage or the peak of the Ca2+ current. Bicuculline and TTX were
included in the TEA-Cl external solution to isolate the Ca2+ current. B: Current recording
from a representative amacrine cell voltage clamped at -70 mV. SNAP still increased
sPSC frequency in the presence of the L-type VGCC inhibitor nifedipine (Nif, 20 µM).
sPSC frequency was unchanged after removal of Nif. C: Quantified mean event
frequency/30 s ± SE, n = 5. *P < 0.05 (repeated measures-ANOVA). D: The NOdependent influx of Ca2+ still occurred in the presence of the NMDAR inhibitor D-AP5 (10
µM) and the AMPAR inhibitor CNQX (50 µM). Data are Mean fluorescence (A.U.) ± SE,
n = 152 ROIs. ****P < 0.0001 (repeated measures-ANOVA).
and application of SKF 96365 (30 µM) alone increased sPSC frequency from baseline
by 431% (control, 33.4 ± 7.5/30 s, SKF 96365, 177.4 ± 44.3, P = 0.044, n = 4, paired ttest). To avoid these confounding effects, clemizole (10 µM), a more specific TRPC
channel blocker (with highest selectivity for TRPC5), was utilized to investigate TRPC
channel involvement in the NO-dependent response. In the presence of clemizole,
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SNAP was unable to increase sPSC frequency (control, 17.2 ± 3.7/30 s,
clemizole/SNAP, 17.9 ± 2.0/30 s, P = 0.84, n = 10, Figure 2.10A-B). When clemizole
was removed, SNAP increased sPSC frequency by 203% (clemizole/SNAP, 17.9 ± 2/30
s, SNAP, 54.1 ± 16.8/30s, P = 0.04, n = 10, Figure 2.10A-B). Additionally, SNAP was
unable to increase process intracellular Ca2+ in the presence of clemizole (clemizole,
5.7 ± 0.4 A.U., clemizole/SNAP, 5.7 ± 0.4 A.U., P = 0.45, n = 46 ROIs, Figure 2.10C-D).
When clemizole was removed, SNAP increased intracellular Ca2+ by 7%
(clemizole/SNAP, 5.7 ± 0.4 A.U., SNAP, 6.1 ± 0.4 A.U., p < 0.0001, n = 46, Figure
2.10C-D). Clemizole is also able to block H1 histamine receptors (Aguilar et al. 1986).
It has been demonstrated that these receptors are functionally expressed in rodent
dopaminergic amacrine cells and that their activation can engender Ca2+ elevations
(Frazao et al. 2011; Gastinger et al. 2006). Although the amacrine cells in our cultures
are GABAergic, we tested whether histamine (10 µM and 100 µM) produced Ca2+
elevations. We found that Ca2+ elevations were not elicited by 10 µM histamine
(control, 5.09 ± 0.25 A.U., 10 µM histamine, 5.05 ± 0.26 A.U., P = 0.16, n = 48) or 100
µM histamine (control, 4.05 ± 0.12 A.U., 100 µM histamine, 4.07 ± 0.12 A.U., P = 0.19,
n = 216) suggesting that either histamine receptors are not expressed or that their
activation is not linked to an increase in cytosolic Ca2+. Together, these results provide
evidence that NO increases GABA release from amacrine cells by activating a TRPCmediated Ca2+ influx.
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Figure 2.10. Clemizole blocks the NO-dependent increase in sPSC frequency and
intracellular Ca2+. A: Current recording from a representative amacrine cell voltage
clamped at -70 mV. Application of the TRPC inhibitor clemizole (clem, 10 µM) and coapplication of clem and the NO donor SNAP (500 µM) did not alter sPSC frequency.
Removal of clem from the bath leaving only SNAP caused an increase in sPSC frequency.
B: Quantified mean event frequency/30 s ± SE, n = 10. *P < 0.05 (repeated measuresANOVA). C: SNAP was unable to increase intracellular Ca2+ during the application of
clem, however, SNAP increased intracellular Ca2+ upon removal of clem. D: Quantified
mean fluorescence ± SE, n = 46. ****P < 0.0001, (repeated measures-ANOVA).
Fluorescence over time data are plotted as mean fluorescence ± SE.
Discussion
These results demonstrate that NO promotes neurotransmitter release at
GABAergic synapses in retinal amacrine cells (ACs). We find that this action of NO is
not dependent on presynaptic action potentials or sGC activity, however, it is dependent
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upon an elevation in cytosolic Ca2+. Both NO-dependent Ca2+ elevations and NOdependent increases in sPSCs were unaffected by store depletion, indicating that Ca2+
influx alone mediates the effects of NO. Evoked GABA release was also enhanced in
the presence of NO, but the activation of voltage-gated Ca2+ channels (VGCCs) was
unaffected by NO. Together, these observations imply that during evoked release, the
NO-dependent Ca2+ elevations can add to the voltage-dependent Ca2+ elevations to
enhance the evoked release of GABA. This interpretation is consistent with the steep
dependence of evoked neurotransmitter release on Ca2+ (Augustine and Charlton 1986;
Dodge and Rahamimoff 1967; Reid et al. 2003). Blocking TRPC channels using
clemizole prevented the NO-dependent increase in sPSC frequency and intracellular
Ca2+. These results suggest that NO activates a TRPC-mediated Ca2+ influx pathway
that is sufficient to drive synaptic exocytosis.
VGCC-independent GABA release
Other mechanisms of VGCC-independent GABA release have been
demonstrated in ACs. Chavez et al. (2006) showed that in the rat retina, reciprocal
GABAergic synapses from A17 ACs onto bipolar cells can be directly stimulated by the
activation of Ca2+-permeable AMPA receptors. Voltage-independent GABA release
was also demonstrated for cultured chick ACs via activation of metabotropic glutamate
receptor 5 (Warrier et al. 2005). Both mechanisms involved amplification through
release of Ca2+ from stores. Additionally, a study of unstimulated GABA release from
cultured rat ACs demonstrated the involvement of both Ca2+ influx and store release (Ke
et al. 2010). The NO-dependent increase in sPSCs reported here is novel because our
results argue against a contribution from stores.
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NO and GABA release
In agreement with our finding in cultured ACs, experiments measuring the levels
of a GABA analog loaded in slices of turtle retina showed that NO promoted GABA
release from ACs as well as horizontal cells (Yu and Eldred 2005). Significantly, in the
inner retina where ACs signal, the NO-dependent increase in GABA release was largely
Ca2+-dependent and soluble guanylate cyclase-independent, consistent with what we
find for cultured ACs. NO has also been reported to stimulate GABA release from
GABAergic cells in the ganglion cell layer (most likely displaced ACs) (Maggesissi et al.
2009) in the intact chicken retina, although the underlying mechanism was not
investigated. Previous studies measuring the effects of NO on GABA release at other
central synapses have demonstrated both enhancement (Merino et al. 2014; Tarasenko
et al. 2014) and inhibition (De Laurentiis et al. 2000; Wall 2003). In studies of the
effects of NO on GABAergic sPSC frequency specifically, both increases in sPSC
frequency (Li et al. 2004; Li et al. 2002; Xing et al. 2008; Yang and Cox 2007) and
decreases in sPSC frequency (Lee 2009) have been reported for central mammalian
synapses. Both effects can be dependent upon soluble guanylate cyclase activity (Lee
2009; Yang and Cox 2008: Li et al. 2004). Here, we show that GABAergic sPSC
frequency is enhanced by NO via a soluble guanylate cyclase-independent mechanism.
Together, these studies establish that the effects of NO on GABAergic signaling can be
functionally and mechanistically diverse, indicating that the effects of NO on the
synaptic output of any one class of neuron is not predictable.
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Role of spontaneous GABA release
There is abundant evidence that spontaneous and action potential (AP) evoked
vesicular neurotransmitter release occur by distinct processes that involve different Ca2+
sensitivities, molecular machinery and synaptic vesicle pools (Kavalali 2015; Smith et al.
2012). This existence of a parallel and similarly complex system of neurotransmitter
release implies that spontaneous release has distinctive functions. One emerging role is
in the regulation of the synapse itself. Most is known about the role of spontaneous
glutamate release in regulating synaptic function, however, recent work has
demonstrated that spontaneous GABA release regulates synaptic scaling in the
embryonic chick spinal cord (Garcia-Bereguiain et al. 2016). The mechanism
underlying this action of GABA depends on the depolarizing effect of GABA at that time
in development, and scaling is achieved by adjusting the level of postsynaptic Cl-. We
have previously demonstrated that NO can release Cl- from an internal store and
transiently convert inhibitory GABAergic synapses into excitatory GABAergic synapses
(Hoffpauir et al. 2006; Krishnan and Gleason 2015). Thus, the ability of GABA to even
transiently generate depolarization-dependent Ca2+ elevations opens the possibility that
NO-dependent spontaneous activity at AC synapses can further modulate their own
synaptic function.
TRPCs in ACs
Our experiments with clemizole suggest that TRPC channels are induced to
admit presynaptic Ca2+ by NO. There is additional evidence in the literature suggesting
the functional expression of TRPC channels in ACs. In cultured rat ACs, the broad
TRPC channel inhibitor SKF96365 reduced GABAergic sPSC frequency, suggesting
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TRPC channels play a role in synaptic output (Ke et al. 2010). In our experiments,
SKF96365 caused an increase in sPSC frequency. In cultured chick ACs, 2-APB was
used to inhibit activation of IP3 receptors which prevented both a depolarization- and
mGluR5-dependent increase in sPSC frequency (Warrier et al. 2005). Here, (in the
absence of depolarization or mGluR5 activation) 2-APB caused an increase in sPSC
frequency. Having multiple sites of action (DeHaven et al. 2008; Hong et al. 1994;
Hotta et al. 2005; Leung et al. 1996; Merritt et al. 1990; Prakriya and Lewis 2001; Singh
et al. 2010; Usmani et al. 2010; Wang 2003), SKF96365 and 2-APB are problematic in
investigating the involvement of TRPC channels in the NO-dependent increase in
intracellular Ca2+ and GABAergic sPSC frequency in cultured ACs. The more specific
TRPC inhibitor clemizole did not activate spontaneous release on its own, but it was
effective in suppressing the effects of NO. Clemizole is most selective for TRPC5 (IC50
= 1.1 μM), however, it can also inhibit TRPC4 (IC50 = 6.4 μM), TRPC3 (IC50 = 9.1 μM),
TRPC6 (IC50 = 11.3 μM) and TRPC7 (IC50 26.5 μM) (Richter et al. 2014). Interestingly,
homomeric TRPC1, TRPC5, or heteromeric TRPC1/5 channels can be activated by Snitrosylation (Yoshida et al. 2006). The effects of the S-nitrosylation inhibitor NEM
alone, however, precluded our use of this reagent to assess the role of this modification.
Transcripts encoding TRPCs 1, 3-7 have been RT-PCR amplified from pools of 10-20
cultured ACs (Crousillac et al. 2009). There is also immunocytochemical evidence that
TRPC1 is expressed by ACs in the chicken retina and can co-localize with nNOS
(Crousillac et al. 2003). The TRPC channel (s) involved in the NO-dependent increase
in intracellular Ca2+ and sPSC frequency remains to be elucidated.

43

References
Aguilar MJ, Morales-Olivas FJ, and Rubio E. Pharmacological investigation into the
effects of histamine and histamine analogues on guinea-pig and rat colon in vitro.
Br J Pharmacol 88: 501-506, 1986.
Augustine GJ, and Charlton MP. Calcium dependence of presynaptic calcium current
and post-synaptic response at the squid giant synapse. J Physiol 381: 619-640,
1986.
Bindoli A, and Fleischer S. Induced Ca2+ release in skeletal muscle sarcoplasmic
reticulum by sulfhydryl reagents and chlorpromazine. Arch Biochem Biophys 221:
458-466, 1983.
Blom J, Giove T, Deshpande M, and Eldred WD. Characterization of nitric oxide
signaling pathways in the mouse retina. J Comp Neurol 520: 4204-4217, 2012.
Cao L, and Eldred WD. Subcellular localization of neuronal nitric oxide synthase in turtle
retina: electron immunocytochemistry. Vis Neurosci 18: 949-960, 2001.
Chavez AE, Grimes WN, and Diamond JS. Mechanisms underlying lateral GABAergic
feedback onto rod bipolar cells in rat retina. J Neurosci 30: 2330-2339, 2010.
Chavez AE, Singer JH, and Diamond JS. Fast neurotransmitter release triggered by Ca
influx through AMPA-type glutamate receptors. Nature 443: 705-708, 2006.
Clary DO, Griff IC, and Rothman JE. SNAPs, a family of NSF attachment proteins
involved in intracellular membrane fusion in animals and yeast. Cell 61: 709-721,
1990.
Cook PB, Lukasiewicz PD, and McReynolds JS. Action potentials are required for the
lateral transmission of glycinergic transient inhibition in the amphibian retina. J
Neurosci 18: 2301-2308, 1998.
Crousillac S, Colonna J, McMains E, Dewey JS, and Gleason E. Sphingosine-1phosphate elicits receptor-dependent calcium signaling in retinal amacrine cells.
J Neurophysiol 102: 3295-3309, 2009.
Crousillac S, LeRouge M, Rankin M, and Gleason E. Immunolocalization of TRPC
channel subunits 1 and 4 in the chicken retina. Vis Neurosci 20: 453-463, 2003.
De Laurentiis A, Pisera D, Duvilanski B, Rettori V, Lasaga M, and Seilicovich A.
Neurokinin A inhibits oxytocin and GABA release from the posterior pituitary by
stimulating nitric oxide synthase. Brain Res Bull 53: 325-330, 2000.
DeHaven WI, Smyth JT, Boyles RR, Bird GS, and Putney JW, Jr. Complex actions of 2aminoethyldiphenyl borate on store-operated calcium entry. J Biol Chem 283:
19265-19273, 2008.

44

DeVries SH, and Schwartz EA. Modulation of an electrical synapse between solitary
pairs of catfish horizontal cells by dopamine and second messengers. J Physiol
414: 351-375, 1989.
Dodge FA, Jr., and Rahamimoff R. Co-operative action a calcium ions in transmitter
release at the neuromuscular junction. J Physiol 193: 419-432, 1967.
Eldred WD, and Blute TA. Imaging of nitric oxide in the retina. Vision Res 45: 34693486, 2005.
Euler T, Detwiler PB, and Denk W. Directionally selective calcium signals in dendrites of
starburst amacrine cells. Nature 418: 845-852, 2002.
Fischer AJ, and Stell WK. Nitric oxide synthase-containing cells in the retina, pigmented
epithelium, choroid, and sclera of the chick eye. J Comp Neurol 405: 1-14, 1999.
Frazao R, McMahon DG, Schunack W, Datta P, Heidelberger R, and Marshak DW.
Histamine elevates free intracellular calcium in mouse retinal dopaminergic cells
via H1-receptors. Invest Ophthalmol Vis Sci 52: 3083-3088, 2011.
Garcia-Bereguiain MA, Gonzalez-Islas C, Lindsly C, and Wenner P. Spontaneous
Release Regulates Synaptic Scaling in the Embryonic Spinal Network In Vivo. J
Neurosci 36: 7268-7282, 2016.
Gastinger MJ, Barber AJ, Vardi N, and Marshak DW. Histamine receptors in
mammalian retinas. J Comp Neurol 495: 658-667, 2006.
Gleason E, Borges S, and Wilson M. Synaptic transmission between pairs of retinal
amacrine cells in culture. J Neurosci 13: 2359-2370, 1993.
Graham S, Ding M, Ding Y, Sours-Brothers S, Luchowski R, Gryczynski Z, Yorio T, Ma
H, and Ma R. Canonical transient receptor potential 6 (TRPC6), a redoxregulated cation channel. J Biol Chem 285: 23466-23476, 2010.
Grimes WN, Zhang J, Graydon CW, Kachar B, and Diamond JS. Retinal parallel
processors: more than 100 independent microcircuits operate within a single
interneuron. Neuron 65: 873-885, 2010.
Grimes WN, Zhang J, Tian H, Graydon CW, Hoon M, Rieke F, and Diamond JS.
Complex inhibitory microcircuitry regulates retinal signaling near visual threshold.
J Neurophysiol 114: 341-353, 2015.
Habermann CJ, O'Brien BJ, Wassle H, and Protti DA. AII amacrine cells express L-type
calcium channels at their output synapses. J Neurosci 23: 6904-6913, 2003.
Haverkamp S, Kolb H, and Cuenca N. Morphological and neurochemical diversity of
neuronal nitric oxide synthase-positive amacrine cells in the turtle retina. Cell
Tissue Res 302: 11-19, 2000.

45

Heflin SJ, and Cook PB. Narrow and wide field amacrine cells fire action potentials in
response to depolarization and light stimulation. Visual Neuroscience 24: 197206, 2007.
Hirooka K, Kourennyi DE, and Barnes S. Calcium channel activation facilitated by nitric
oxide in retinal ganglion cells. J Neurophysiol 83: 198-206, 2000.
Hoffpauir B, McMains E, and Gleason E. Nitric oxide transiently converts synaptic
inhibition to excitation in retinal amacrine cells. J Neurophysiol 95: 2866-2877,
2006.
Hong SJ, Lin WW, and Chang CC. Inhibition of the Sodium Channel by SK&F 96365,
an Inhibitor of the Receptor-Operated Calcium Channel, in Mouse Diaphragm. J
Biomed Sci 1: 172-178, 1994.
Hotta A, Kim YC, Nakamura E, Kito Y, Yamamoto Y, and Suzuki H. Effects of inhibitors
of nonselective cation channels on the acetylcholine-induced depolarization of
circular smooth muscle from the guinea-pig stomach antrum. J Smooth Muscle
Res 41: 313-327, 2005.
Kavalali ET. The mechanisms and functions of spontaneous neurotransmitter release.
Nat Rev Neurosci 16: 5-16, 2015.
Ke JB, Chen W, Yang XL, and Wang Z. Characterization of spontaneous inhibitory
postsynaptic currents in cultured rat retinal amacrine cells. Neuroscience 165:
395-407, 2010.
Kim IB, Lee EJ, Kim KY, Ju WK, Oh SJ, Joo CK, and Chun MH. Immunocytochemical
localization of nitric oxide synthase in the mammalian retina. Neurosci Lett 267:
193-196, 1999.
Kim KY, Ju WK, Oh SJ, and Chun MH. The immunocytochemical localization of
neuronal nitric oxide synthase in the developing rat retina. Exp Brain Res 133:
419-424, 2000.
Kirmse K, and Kirischuk S. N-ethylmaleimide increases release probability at
GABAergic synapses in layer I of the mouse visual cortex. Eur J Neurosci 24:
2741-2748, 2006.
Knight D, Bellingham MC, and Lavidis NA. The effect of N-ethylmaleimide on transmitter
release from the skeletal neuromuscular junction of Bufo marinus. Synapse 53:
151-158, 2004.
Krishnan V, and Gleason E. Nitric oxide releases Cl(-) from acidic organelles in retinal
amacrine cells. Front Cell Neurosci 9: 213, 2015.

46

Lee JJ. Nitric oxide modulation of GABAergic synaptic transmission in mechanically
isolated rat auditory cortical neurons. Korean J Physiol Pharmacol 13: 461-467,
2009.
Leung YM, Kwan CY, and Loh TT. Dual effects of SK&F 96365 in human leukemic HL60 cells. Inhibition of calcium entry and activation of a novel cation influx
pathway. Biochem Pharmacol 51: 605-612, 1996.
Li DP, Chen SR, Finnegan TF, and Pan HL. Signalling pathway of nitric oxide in
synaptic GABA release in the rat paraventricular nucleus. J Physiol 554: 100110, 2004.
Li DP, Chen SR, and Pan HL. Nitric oxide inhibits spinally projecting paraventricular
neurons through potentiation of presynaptic GABA release. J Neurophysiol 88:
2664-2674, 2002.
Maggesissi RS, Gardino PF, Guimaraes-Souza EM, Paes-de-Carvalho R, Silva RB, and
Calaza KC. Modulation of GABA release by nitric oxide in the chick retina:
different effects of nitric oxide depending on the cell population. Vision Res 49:
2494-2502, 2009.
Merino JJ, Arce C, Naddaf A, Bellver-Landete V, Oset-Gasque MJ, and Gonzalez MP.
The nitric oxide donor SNAP-induced amino acid neurotransmitter release in
cortical neurons. Effects of blockers of voltage-dependent sodium and calcium
channels. PLoS One 9: e90703, 2014.
Merritt JE, Armstrong WP, Benham CD, Hallam TJ, Jacob R, Jaxa-Chamiec A, Leigh
BK, McCarthy SA, Moores KE, and Rink TJ. SK&F 96365, a novel inhibitor of
receptor-mediated calcium entry. Biochem J 271: 515-522, 1990.
Mills SL, and Massey SC. Differential properties of two gap junctional pathways made
by AII amacrine cells. Nature 377: 734-737, 1995.
Miyachi E, Murakami M, and Nakaki T. Arginine blocks gap junctions between retinal
horizontal cells. Neuroreport 1: 107-110, 1990.
Pan L, Wu X, Zhao D, Hessari NM, Lee I, Zhang X, and Xu J. Sulfhydryl modification
induces calcium entry through IP(3)-sensitive store-operated pathway in
activation-dependent human neutrophils. PLoS One 6: e25262, 2011.
Pang JJ, Gao F, and Wu SM. Light responses and morphology of bNOSimmunoreactive neurons in the mouse retina. J Comp Neurol 518: 2456-2474,
2010.
Peters JM, Walsh MJ, and Franke WW. An abundant and ubiquitous homo-oligomeric
ring-shaped ATPase particle related to the putative vesicle fusion proteins
Sec18p and NSF. EMBO J 9: 1757-1767, 1990.

47

Prakriya M, and Lewis RS. Potentiation and inhibition of Ca(2+) release-activated
Ca(2+) channels by 2-aminoethyldiphenyl borate (2-APB) occurs independently
of IP(3) receptors. J Physiol 536: 3-19, 2001.
Reid CA, Bekkers JM, and Clements JD. Presynaptic Ca2+ channels: a functional
patchwork. Trends Neurosci 26: 683-687, 2003.
Richter JM, Schaefer M, and Hill K. Clemizole hydrochloride is a novel and potent
inhibitor of transient receptor potential channel TRPC5. Mol Pharmacol 86: 514521, 2014.
Rothman JE. The protein machinery of vesicle budding and fusion. Protein Sci 5: 185194, 1996.
Singh A, Hildebrand ME, Garcia E, and Snutch TP. The transient receptor potential
channel antagonist SKF96365 is a potent blocker of low-voltage-activated T-type
calcium channels. Br J Pharmacol 160: 1464-1475, 2010.
Smith SM, Chen W, Vyleta NP, Williams C, Lee CH, Phillips C, and Andresen MC.
Calcium regulation of spontaneous and asynchronous neurotransmitter release.
Cell Calcium 52: 226-233, 2012.
Tarasenko A, Krupko O, and Himmelreich N. New insights into molecular mechanism(s)
underlying the presynaptic action of nitric oxide on GABA release. Biochim
Biophys Acta 1840: 1923-1932, 2014.
Tekmen-Clark M, and Gleason E. Nitric oxide production and the expression of two
nitric oxide synthases in the avian retina. Vis Neurosci 30: 91-103, 2013.
Tooker RE, and Vigh J. Light-evoked S-nitrosylation in the retina. J Comp Neurol 523:
2082-2110, 2015.
Tozer AJ, Forsythe ID, and Steinert JR. Nitric oxide signalling augments neuronal
voltage-gated L-type (Ca(v)1) and P/q-type (Ca(v)2.1) channels in the mouse
medial nucleus of the trapezoid body. PLoS One 7: e32256, 2012.
Tsukamoto Y, Morigiwa K, Ueda M, and Sterling P. Microcircuits for night vision in
mouse retina. J Neurosci 21: 8616-8623, 2001.
Usmani SM, Fois G, Albrecht S, von Aulock S, Dietl P, and Wittekindt OH. 2-APB and
capsazepine-induced Ca2+ influx stimulates clathrin-dependent endocytosis in
alveolar epithelial cells. Cell Physiol Biochem 25: 91-102, 2010.
Vigh J, and Lasater EM. L-type calcium channels mediate transmitter release in
isolated, wide-field retinal amacrine cells. Vis Neurosci 21: 129-134, 2004.
Wall MJ. Endogenous nitric oxide modulates GABAergic transmission to granule cells in
adult rat cerebellum. Eur J Neurosci 18: 869-878, 2003.

48

Wang GY, Liets LC, and Chalupa LM. Nitric oxide differentially modulates ON and OFF
responses of retinal ganglion cells. J Neurophysiol 90: 1304-1313, 2003.
Wang JP. GEA3162 stimulates Ca2+ entry in neutrophils. Eur J Pharmacol 458: 243249, 2003.
Warrier A, Borges S, Dalcino D, Walters C, and Wilson M. Calcium from internal stores
triggers GABA release from retinal amacrine cells. J Neurophysiol 94: 41964208, 2005.
Watanabe S-I, Koizumi A, Yamada Y, and Kaneko A. Functional Roles of Action
Potentials and Na Currents in Amacrine Cells. In: The Neural Basis of Early
Vision, edited by Kaneko ASpringer Japan, 2003, p. 55-58.
Xing J, Li DP, and Li J. Role of GABA receptors in nitric oxide inhibition of dorsolateral
periaqueductal gray neurons. Neuropharmacology 54: 734-744, 2008.
Yang S, and Cox CL. Modulation of inhibitory activity by nitric oxide in the thalamus. J
Neurophysiol 97: 3386-3395, 2007.
Yoshida T, Inoue R, Morii T, Takahashi N, Yamamoto S, Hara Y, Tominaga M, Shimizu
S, Sato Y, and Mori Y. Nitric oxide activates TRP channels by cysteine Snitrosylation. Nat Chem Biol 2: 596-607, 2006.
Yu D, and Eldred WD. Nitric oxide stimulates gamma-aminobutyric acid release and
inhibits glycine release in retina. J Comp Neurol 483: 278-291, 2005.

49

CHAPTER 3
TRPC5 IS REQUIRED FOR THE NO-DEPENDENT INCREASE IN
DENDRITIC CA2+ AND GABA RELEASE FROM
RETINAL AMACRINE CELLS
Introduction
Retinal amacrine cells (ACs) play a major role in processing the visual signal in
the retina before the signal is sent to the visual cortex of the brain. There are ~40
different morphological AC subtypes, and some subtypes of ACs are involved in
dopamine-dependent light adaptation (Mills and Massey 1995; Xia and Mills 2004), rod
pathway integration into the cone pathway (Vaney et al. 1991), and direction selectivity
(Taylor and Smith 2012). The function of majority AC subtypes have not been identified,
including nitric oxide (NO) producing ACs. Our lab has identified two roles NO plays in
regulating AC signaling. NO induces Cl- release from internal acidic organelles, which
can transiently convert typical inhibitory synapses into excitatory (Hoffpauir et al. 2006;
Krishnan and Gleason 2015), and NO enhances the release of Ca2+ dependent GABA
release by activating a Ca2+ influx pathway (Maddox and Gleason 2017).
The enzyme nitric oxide synthase (NOS) synthesizes NO by catalyzing Larginine into L-citrulline and NO. The two Ca2+-sensitive NOS isoforms, endothelial
NOS (eNOS) and neuronal NOS (nNOS), have been localized to ACs, as well as other
retinal cell types (Fischer and Stell 1999; Haverkamp et al. 2000; Kim et al. 1999; Pang
et al. 2010; Tekmen-Clark and Gleason 2013). Neuronal NOS has been specifically
localized to AC presynaptic terminals in the inner turtle retina (Cao and Eldred 2001),
and NO stimulates Ca2+ dependent GABA release from ACs, independent of the
canonical NO receptor soluble guanylate cyclase (Maddox and Gleason 2017; Yu and
Eldred 2005). In some tissues, NO is traditionally considered a diffusible signaling
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molecule, however, studies that monitored endogenous NO production in retinas loaded
with the NO fluorescent indicator DAF-FM have demonstrated that NO is largely
confined to cellular boundries in turtle (Eldred and Blute 2005), mice (Blom et al. 2012),
and chicken (Tekmen-Clark and Gleason 2013) retinas, suggesting that NO synthesis
may affect neurotransmitter release from NO producing cells or from their immediate
synaptic partners.
We previously determined that the NO-dependent increase in dendritic Ca2+ and
GABA release relied on a likely transient receptor potential canonical (TRPC)-mediated
Ca2+ influx pathway (Maddox and Gleason 2017). Interestingly, it has been shown that
NO can directly activate TRPC channels via S-nitrosylation (Shimizu et al. 2014;
Yoshida et al. 2006). S-nitrosylation is a posttranslational modification that can alter the
function of a protein and occurs when NO binds to a cysteine thiol group. In the mouse
retina, TRPC1, -4, and -5 are present in the inner plexiform layer (IPL), where ACs form
synapses, and TRPC3, -6, and -7 is mostly absent (Witkovsky et al. 2008). In the
mouse IPL, TRPC5 is the most abundant TRPC subunit (Witkovsky et al. 2008). In the
chicken retina, TRPC1 expression has been demonstrated in the IPL and TRPC4 is
expressed by Müller cells (Crousillac et al. 2003).
We previously demonstrated that clemizole, an inhibitor for TRPC5, -4, -3, -6,
and -7 (IC50 = 1.1, 6.4, 9.1, 11.3, and 26.5 µM, respectively) (Richter et al. 2014),
prevented the NO-dependent dendritic Ca2+ elevation and the increase in GABAergic
spontaneous postsynaptic current (sPSC) frequency (Maddox and Gleason 2017). To
identify the TRPC family member involved in the NO-dependent enhancement of GABA
release, we employed whole-cell current recordings, Ca2+ imaging,
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immunocytochemistry, and a CRISPR/Cas9 protein knockdown strategy. In the present
study, we find that downstream activity of phospholipase C (PLC) is required for the
NO-dependent increase in sPSC frequency. PLC cleaves phosphatidylinositol-4,5bisphosphate (PIP2) into the secondary messengers inositol trisphosphate (IP3) and
diacylglycerol (DAG). DAG can activate TRPC3, -6, and -7, however, it is thought that
TRPC4 and -5 are inhibited by PIP2 but can be activated once PLC cleaves PIP2 to
relieve inhibition (Svobodova and Groschner 2016). We also show that La3+ has a
biphasic, concentration-dependent effect on sPSC frequency, consistent with TRPC4
and 5 expression. The TRPC4/C5 inhibitor ML204 had no effect on the NO response at
10 µM but blocked the NO response at 20 µM. Using the CRISPR/Cas9 system to
target the 2nd exon of the TRPC5 gene, we find that TRPC5 protein expression is
required for the NO-dependent Ca2+ influx and GABAergic sPSC frequency increase.
These findings provide evidence that the NO-dependent activation of TRPC5 can
enhance GABA release from amacrine cell synapses, which suggests that NOdependent TRPC5 activity enhances inhibition in the inner retina.
Methods
Plasmid construction
pSpCas9(BB)-2A-GFP (PX458) was a gift from Feng Zhang (Addgene plasmid #
48138) (Ran et al. 2013). Due to the overlapping excitation/emission wavelengths of
GFP and the Ca2+ indicator Oregon Green 488 BAPTA-1, AM (OGB, Life Technologies,
Carlsbad, CA), the GFP gene in pSpCas9(BB)-2A-GFP (PX458) was replaced with
tdTomato gene from tdTomato-N1 (Addgene plasmid #54642) to create pSpCas9-2AtdTomato. tdTomato-N1 was a gift from Michael Davidson and Roger Tsien. The
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inverted repeat BbsI restriction sites needed to clone the 20-nt guide RNA sequence
into pSpCas9(BB)-2A-GFP also occurs twice within the tdTomato gene. The BbsI
restriction sites in pSpCas9(BB)-2A-GFP were replaced with inverted repeat BsaI
restriction sites prior to replacing GFP with tdTomato. Oligos used to clone the BsaI
restriction sites into pSpCas9(BB)-2A-GFP were BsaI-F:
CACCGGAGACCGAGGTCTCC and BsaI-R: AAACGGAGACCTCGGTCTCC. A 20-nt
guide sequence (AAAAGGGCACTCCGACCAAG) with a quality score of 95 was
designed using the CRISPR design portal (crispr.mit.edu) to target Cas9 to the 2nd exon
of TRPC5. Oligos used to clone the 20 bp TRPC5 guide sequence into pSpCas9-2AtdTomato were sgTRPC5-F: caccgAAAAGGGCACTCCGACCAAG and sgTRPC5-R:
aaacCTTGGTCGGAGTGCCCTTTTc. The 20 bp guide sequence for TRPC5 was
cloned into pSpCas9-2A-tdTomato to create pCRISPR-TRPC5. All oligos were
synthesized by Integrated DNA Technologies (Coralville, IA).
Amacrine cell cultures and transfections
The use of chick embryos to prepare retinal cultures was determined to be
exempt by the LSU Institutional Animal Care and Use Committee. Retinal cell cultures
were prepared and maintained as previously described (Maddox and Gleason 2017).
Experiments were performed on ACs that had been in culture for 8-13 days (embryonic
equivalent days 16 to 21). Over this time in culture, AC-to-AC GABAergic synapses are
functional. ACs were identified on morphological criteria (Gleason et al. 1993).
Dissociated retinas (~8 x 106 cells) from 8-day chick embryos were pelleted and
resuspended with 100 µL PBS supplemented with 1 mM CaCl, 5 mM glucose, and
either 5 µg of pSpCas9-tdTomato (–sgRNA) or 5 µg pCRISPR-TRPC5 (+sgRNA). Cell
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suspensions were electroporated using Nucleofector II device, program G-013 (Lonza,
Basel, Switzerland). Dulbecco’s Modified Eagle Medium (DMEM) supplemented with
5% fetal bovine serum (Thermo Fisher Scientific, Waltham, MA) was added to the
electroporated cell suspension and allowed to rest for 5 min. Transfected cells used for
current recording/Ca2+ imaging experiments and transfected cells used for
immunocytochemistry were plated onto tissue culture dishes pretreated with 0.01%
poly-DL-ornithine hydrobromide (Sigma Aldrich, St. Louis, MO) and coverslips
pretreated with 0.01% poly-DL-ornithine hydrobromide at a density of ~1 x 106 cells pretransfection, respectively. DMEM was replaced 24 hrs after initial plating with
Neurobasal medium supplemented with 1% serum-free B-27, penicillin (100 U/mL),
streptomycin (100 µg/mL) and glutamine (2 mM).
Solutions
All reagents were purchased from Sigma-Aldrich unless otherwise stated.
Tetraethylammonium (TEA)-Cl external solution (in mM): NaCl (117), KCl (5.3), TEA-Cl
(20), CaCl2 (3), MgCl2 (0.41), glucose (5.6), HEPES (10), pH 7.4. High Cl- internal
solution (in mM): CsCl (110), MgCl2 (2), CaCl2 (0.1), EGTA (1), HEPES (10), NaCl2 (1),
ATP-2Na+ (3), ATP- 2K+ (1), GTP (2), phosphocreatine (20), creatine phosphokinase
(50 U/mL), pH 7.4. The high Cl- content of these internal and external solutions sets the
reversal potential for Cl- at 0 mV and allows spontaneous presynaptic quantal events to
easily be resolved during current recordings in postsynaptic amacrine cells voltageclamped at -70 mV (Borges et al. 1995; Gleason et al. 1993; Maddox and Gleason
2017). For imaging experiments, the following external solutions were used: Normal
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external solution (in mM): NaCl (137), KCl (5.37), CaCl2 (3), MgCl2 (0.41), glucose (5.6),
HEPES (3.02), pH 7.4.
Reagents
The NO donor S-nitroso-N-acetyl-D,L-penicillamine (SNAP, 500 µM, Enzo,
Farmingdale, NY) and LaCl3 (2 mM and 10 µM) were dissolved directly into the external
solution. 4-Methyl-2-(1-piperidinyl)quinolone (ML 204, Tocris Bioscience, Bristol, UK),
1-[6-[[(17β)-3-Methoxyestra-1,3,5(10)-trien-17-yl]amino]hexyl]-1H-pyrrole-2,5-dione (U
73122, Tocris), and 1-[6-[[(17β)-3-Methoxyestra-1,3,5(10)-trien-17-yl]amino]hexyl]-2,5pyrrolidinedione (U 73343, Tocris) were prepared as 1000 X stocks in DMSO and
diluted to 1 X into the external solution. The external solution pH was readjusted to 7.4
after the addition of reagents.
Electrophysiology
Whole-cell voltage clamp recordings were performed using Axopatch 1D
amplifier, Digidata 1322A data-acquisition board, and Clampex 10.0 (Molecular
Devices, Sunnyvale, CA). Patch pipette electrodes with a tip resistance between 5-10
MΩ were pulled from thick-walled borosilicate glass (1.5 mm O.D., 0.86 mm I.D.) using
a P-97 Flaming/Brown Puller (Sutter Instruments, Novato, CA). A reference Ag/AgCl
electrode pellet was placed in 3 M KCl and connected to the culture dish with a 3 M KCl
agarose bridge. Recordings were performed at room temperature (22-24°C). A
pressurized perfusion system (AutoMate Scientific, Berkeley, CA) was used to deliver
external solutions at a flow rate of 1 mL/min. Recordings were performed on
postsynaptic ACs whose processes were in contact with unclamped presynaptic ACs
and that had spontaneous postsynaptic currents (sPSCs). Transfected cell recordings
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were performed on postsynaptic tdTomato-expressing cells that were in contact with
other tdTomato expressing cells. Cells that did not have basal sPSCs also did not
respond to SNAP and were excluded from the analysis.
Calcium imaging
The fluorescent Ca2+ indicator OGB (2 µM) was prepared as previously
described (Maddox and Gleason 2017). Images were taken every 3 s (200 ms
exposure). To obtain data relevant to synaptic function, regions of interest (ROIs) were
chosen at sites of contact between processes. Images were captured on an inverted
Olympus IX70 microscope (Tokyo, Japan) fitted with a SensiCam QE (Cooke, Kelheim,
Germany). ROIs used to obtain data in transfected cell processes expressing tdTomato
were selected in the tdTomato channel (ex: 554, em: 581) prior to Ca2+ imaging (ex:
494, em: 523). Data were collected and analyzed using Slidebook software (Intelligent
Imaging Innovations, Denver, CO). In all Ca2+ imaging experiments, the control
fluorescence mean was calculated by using the average of the last 10 ROI time points
before switching solutions, and the fluorescence means after switching solutions were
calculated by using the 10 ROI time points from the middle of each solution application.
The control and different solution fluorescence means were used to calculate percent
change in fluorescence.
Immunocytochemistry
Transfected and non-transfected cells on coverslips were fixed using 2%
paraformaldehyde in PBS for 30 min at 4 °C and then washed 4 X with 30 mM glycine in
PBS. The last wash contained 0.1% triton X-100 for membrane permeabilization. Fixed
cells were immediately blocked with 5% normal goat serum in dilution solution (1%
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BSA/0.5% saponin in PBS) for 30 min at 4 °C. TRPC5 primary monoclonal antibody
(Sigma-Aldrich, Cat: SAB140977) was diluted in dilution solution (5 µg/mL) and
incubated for 2 hrs at room temperature. Goat anti-mouse Dylight-488 (Thermo Fisher
Scientific) secondary antibody was diluted 1:500 in dilution solution and incubated for 1
hr at room temperature. Coverslips were mounted on plain glass microscope slides
(Thermo Fisher) using ProLong Diamond Antifade Mountant with DAPI (Thermo Fisher)
and cured overnight. Labeled cells were viewed on an inverted Olympus IX70
microscope (Tokyo, Japan), fitted with a SensiCam QE (Cooke, Kelheim, Germany).
Images were captured and analyzed using Slidebook 5.5 software (Intelligent Imaging
Innovations, Denver, CO).
Immunohistochemistry
The use of adult chickens to prepare retinal sections and brain protein preps was
approved by the LSU Institutional Animal Care and Use Committee. Adult white leghorn
chickens (4-7 weeks old) were sacrificed by intraperitoneal injection of 250 mg/kg
sodium pentobarbital (Sigma-Aldrich) and decapitated. Eyes were enucleated and
hemisected. The eye cup was fixed in 4% paraformaldehyde for 1 hr at room
temperature. The retina was removed and was washed 3 X with PBS containing 1%
glycine. Retinas were infused with 15% sucrose for 30 min, 20% sucrose for 1 hr, and
30% sucrose at 4°C overnight. Retinas were placed in 1:1 v/w 30% sucrose and O.C.T.
compound (Sakura Finetek, Torrence, CA) for 30 min. Retinas in fresh sucrose/OCT
mixture were frozen in a dry ice/isopentane bath. Retinas were cryosectioned at ~15-18
µm on a Leica CM1850 cryostat (Wetzlar, Germany) and mounted on Superfrost Plus
Micro Slides (VWR, Radnor, PA).
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Sections were washed PBS for 10 min to remove the sucrose/O.C.T. mixture and
blocked with 5% normal goat serum in dilution solution at 4 °C for 30 min. The primary
TRPC5 antibody (Sigma-Aldrich) was diluted (5 µg/mL) in dilution solution and
incubated on blocked sections overnight at 4 °C. Sections were washed 3 X with PBS.
The goat anti-mouse Dylight-555 secondary antibody (Thermo Fisher) was diluted 1:500
in dilution solution and incubated in the dark for 1 hr at room temperature. Labeled
sections were mounted with #1.5 coverslips using ProLong Diamond Antifade mountant
with DAPI (Thermo Fisher). Labeled sections were viewed using an inverted Leica TCS
SP8 Spectral confocal microscope (Leica Microsystems, Wetzlar, Germany) with a 40X
oil immersion objective (1.25 N.A.). Dylight-555 was observed with white light laser set
to 562 nm with HyD detector emission collection from 573-600 nm. Images were
captured using the Leica LAS X software package. Each z-plane was an average of 32
line scans with 0.3 µm steps. The brightness of sum intensity projection images of 40 zplanes were adjusted using ImageJ (NIH).
Western blot
Adult chickens were sacrificed as described above. Chicken brains were flash
frozen with liquid nitrogen and stored at -80°C until use. Brains were homogenized on
ice in radioimmunoprecipitation assay buffer (150 mM NaCl, 1% Triton X-100, 0.5%
sodium deoxycholate, 0.1% sodium dodecyl sulphate, 50 mM Tris, pH 8.0) containing
phosphatase inhibitor cocktail 2 (Sigma-Aldrich) and protease inhibitor cocktail (SigmaAldrich). Homogenates were centrifuged at 17,000 x g for 20 min at 4°C. The
supernatant was immediately aliquoted and stored at -80°C. Protein concentration was
determined using the BCA Protein Assay Kit from Pierce (Rockford, IL). Prior to
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electrophoresis, protein samples were prepared in Laemmli buffer containing 2% SDS,
5% 2-metcaptoethanol, 10% glycerol, 0.005% bromophenol blue, and 62.5 mM Tris.
Protein samples (20 µg) in Laemmli buffer were incubated at 60 °C for 30 min. Proteins
were separated on an 8% bis-acrylimide/SDS gel with 10 µL of Precision Plus Protein
Dual Color Standard (BioRad, Hercules, CA). Separated proteins were transferred onto
nitrocellulose membrane at 4 °C overnight. The membrane was blocked with 1X
blocking buffer (Abcam, Cambridge, MA) in Tris-buffered saline with 0.1% Tween 20
(TBS-T) for 1 hr at room temperature. The blocking buffer was replaced with the diluted
primary anti-TRPC5 antibody (1:1000) in 1X blocking buffer/TBS-T and incubated
overnight at 4 °C. The membrane was washed 3 X with TBS-T. The goat anti-mouse
secondary antibody conjugated with horseradish peroxidase (BioRad) was diluted
1:5,000 in 1X blocking buffer/TBS-T. The membrane was incubated with the secondary
antibody for 1 hr. The membrane was washed three times with TBS-T. Protein was
visualized using the Clarity chemiluminescence kit (BioRad) and the ChemiDoc XRS+
system (BioRad). Western blot images were captured using the Image Lab Software
(BioRad).
TRPC5 gene mutation analysis
To detect indels (insertions/deletions) in the 2nd exon of TRPC5 by nonhomologous end joining induced by Cas9-mediated dsDNA cleavage, genomic DNA
(gDNA) from whole dishes containing transfected and non-transfected cells was isolated
using Arcturus PicoPure kit (Thermo Fisher). The 2nd exon of TRPC5 was PCR
amplified using Q5 Hotstart High Fidelity DNA polymerase (New England Biolabs,
Ipswich, MA) and primers that were designed to anneal within the introns flanking the
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2nd exon (gDNA-TRPC5-F: GGGGTTAGTCGTGGAGCATT; gDNA-TRPC5-R:
GTACCACATTTGCTCTGGGC). Correct PCR amplification was verified by sequencing
(Eurofins Genomics, Louisville, KY). Purified gDNA PCR products (~721 bp) from
pCRISPR-TRPC5 transfections and pSpCas9-tdTomato transfections were used in the
T7 Endonuclease I (T7E1) mutation detection assay (NEB), which recognizes and
cleaves mismatched dsDNA. PCR products (200 ng) from each gDNA amplification
(pCRISPR-TRPC5 transfections and pSpCas9-2A-tdTomato) were denatured and
slowly reannealed to allow heteroduplex formation. Each heteroduplexed DNA sample
was digested with T7E1 (10 U) for 30 min at 37 °C. DNA (50 ng) from each T7E1
digestion was separated by 2% agarose gel electrophoresis, stained with ethidium
bromide, and visualized using the ChemiDoc XRS+ system (BioRad). Images were
captured and analyzed using the Image Lab Software (BioRad).
Data analysis
For sPSC electrophysiology experiments, Mini Analysis Program (Synaptosoft,
Inc, Fort Lee, NJ) was used to detect and analyze sPSCs. For immunocytochemistry
experiments on transfected cells, slidebook software (Intelligent Imaging Innovations)
was used to create a threshold mask in the TRPC5 channel based on non-transfected
cells labeled with only the secondary antibody. The threshold mask for TRPC5 was
applied to images of cells transfected with pSpCas9-tdTomato (Control) and pCRISPRTRPC5 (TRPC5 KD). Due to their thickness, cell bodies were removed from the TRPC5
mask in all images, and only processes with tdTomato expression were used for
analysis. Slidebook software automatically calculated TRPC5 mask descriptive
statistics for TRPC5 objects > 5 pixels for total TRPC5 object area, TRPC object size,
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TRPC5 object intensity, and tdTomato intensity in TRPC5 object area. Welch’s t-tests
were performed on TRPC5 mask descriptive statistics. Repeated Measures-ANOVA
with Fisher’s Least Significant Difference (LSD) post hoc analysis was performed on all
Ca2+ imaging and electrophysiology data unless otherwise indicated. Statistics were
performed using GraphPad Prisim 7 (GraphPad Software, La Jolla, CA). Data are
reported as mean ± SE.
Results
PLC activity is required for the NO-dependent GABA release from retinal ACs
We previously demonstrated that nitric oxide (NO) enhances spontaneous and
evoked Ca2+-dependent GABA release by activating a transient receptor potential
canonical (TRPC) channel-mediated Ca2+ influx pathway, without the requirement of
Ca2+ stores, action potentials, or activation of the NO receptor sGC (Maddox and
Gleason 2017). All TRPC family members (1-7) are known to be activated, albeit by
different mechanisms, by downstream phospholipase C (PLC) activity (Svobodova and
Groschner 2016). To determine if PLC activity is required for the NO-dependent
increase in spontaneous postsynaptic current (sPSC) frequency, the effects of the
broad PLC inhibitor U73122 (10 µM) was tested. The NO donor SNAP (500 µM)
caused a significant increase in sPSC frequency by 68.3% (control, 24.9 ± 8.4/30 s,
SNAP, 41.9 ± 10.3/30 s, P = 0.0012, n = 8, Figure 3.1A,B). Application of the PLC
inhibitor U73122 together with SNAP significantly reduced the NO-dependent increase
in sPSC frequency by 74.1% (SNAP, 41.9 ± 10.3/30 s, SNAP/U 73122, 10.89 ± 2.5/30
s, P = 0.017, n = 8, Figure 3.1A,B). U73343 (the less active analog of U73122) did not
influence the NO-dependent increase in sPSC frequency (SNAP, 38.6 ± 9.8/30 s,
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SNAP/U 73343, 37.8 ± 6.0/30 s, P = 0.85, n = 8, Figure 3.1C,D). Additionally,
application of U73122 alone significantly reduced basal sPSC frequency by 61.5%
(control, 15.81 ± 3.3/30 s, U73122, 6.09 ± 0.92/30 s, P = 0.0096, n = 10, paired t-test,
Figure 3.1E,F). U73343, however, did not alter basal sPSC frequency (control, 38.7 ±
12.04/30 s, U73343, 28.96 ± 6.9/30 s, P = 0.23, n = 6, paired t-test, Figure 3.1E,F).
These results suggest PLC activity is required for basal spontaneous GABA release.
Although TRPC channels can be activated independent of PLC activity, the NOdependent increase in spontaneous GABA release cannot overcome the requirement of
PLC activity.
The NO-dependent increase in sPSC frequency is sensitive to La3+
We have previous shown that the NO-dependent increase in cytosolic Ca2+ and
sPSC frequency is blocked by clemizole, a TRPC channel inhibitor with highest affinity
for TRPC5 and TRPC4, respectively (Maddox and Gleason 2017). Additionally, we now
show that downstream PLC activity is required for the NO-dependent increase in sPSC
frequency. Together, these findings argue for the involvement of a TRPC channel,
possibly TRPC4 or TRPC5. Unique to TRPC4 and TRPC5, mM concentrations of
lanthanides block these channels currents and µM concentrations potentiate channel
activity (Jung et al. 2003). To test whether TRPC4 or TRPC5 are involved, the effects of
La3+ were evaluated. In 2 mM La3+, SNAP was unable to increase sPSC frequency (2
mM La3+, 5.4 ± 1.9/30 s, 2 mM La3+/SNAP, 4.8 ± 1.4/30 s, P = 0.52, n = 8, Figure
3.2A,B). When 2 mM La3+ was removed, SNAP caused a significant increase in sPSC
frequency by 639% (SNAP/La3+, 4.8 ± 1.4/30 s, SNAP, 35.3 ± 13.4/30 s, P = 0.04, n =
8, Figure 3.2A,B). Conversely, after NO caused a significant increase in sPSC
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frequency (control, 20.08 ± 4.97/30 s, SNAP, 32.23 ± 6.26/30 s, P = 0.025, n = 9, Figure
3.2C,D), 10 µM La3+ enhanced the NO-dependent increase in sPSC frequency by
77.5% (SNAP, 32.23 ± 6.26/30 s, SNAP/10 µM La3+, 57.23 ± 12.96/30 s, P = 0.018, n =
9, Figure 3.2C,D). This differential effect of La3+ on sPSC frequency suggests that the
NO-dependent increase in sPSC frequency is mediated by TRPC4 and/or TRPC5.

Figure 3.1. PLC activity is required for the NO-dependent increase in sPSC frequency. A:
representative recording from a postsynaptic AC voltage clamped at -70 mV. The PLC
inhibitor U73122 (10 µM) reduced the NO-dependent increase in sPSC frequency. B:
quantified mean event frequency/30 s ± SE; n = 10. *P < 0.05, **P <0.01. C:
representative recording from a postsynaptic AC voltage clamped at -70 mV. The less
active U73343 (10 µM) did not affect the NO-dependent increase in sPSC frequency. D:
quantified mean event frequency/30 s ± SE; n = 6. *P < 0.05, **P <0.01. E,F:
representative recordings from postsynaptic ACs voltage clamped at -70 mV. Perfusion
of only U73122 reduced sPSCs frequency (E). Perfusion of only U73343 had no effect on
sPSC frequency (F). G,H: quantified mean event frequency/30 s ± SE; n = 10 (G), n = 6
(H). **P < 0.01 (paired t-test).
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Figure 3.2. The NO-dependent increase in sPSC frequency is sensitive to La3+. A:
representative recording from postsynaptic AC voltage clamped at -70 mV. 2 mM La3+
prevented the NO-dependent increase in sPSC frequency when exposed to the NO donor
SNAP. When 2 mM La3+ was removed and SNAP remained, NO increased the sPSC
frequency. B: quantified mean event frequency/30 s ± SE; n = 8. *P < 0.05. C:
representative recordings from postsynaptic ACs voltage clamped at -70 mV. 10 µM La3+
enhanced the NO-dependent increase in sPSC frequency. D: quantified mean event
frequency/30 s ± SE; n = 9. *P < 0.05, **P < 0.01.
ML204 can block the NO-dependent increase in cytosolic Ca2+
ML204 preferentially inhibits TRPC4 channels with an IC50 of 1 µM in Ca2+
imaging and 3 µM in whole-cell current recordings (Miller et al. 2011). In over
expression cell lines, 10 µM ML204 nearly inhibits TRPC4 currents completely and
inhibits TRPC5 currents by ~ 68 % (Miller et al. 2011), suggesting that higher
concentrations of ML204 are needed to sufficiently block TRPC5. To determine if 10 µM
ML204 can block the NO-dependent increase in cytosolic Ca2+, changes in cytosolic
Ca2+ in regions of process contacts (potential synaptic sites) were monitored using the
fluorescent Ca2+ indicator Oregon Green BAPTA-488 that was preloaded into ACs.
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ML204 alone had no effect on cytosolic Ca2+ (control, 8.19 ± 0.59 A.U., 10 µM ML204,
8.09 ± 0.58 A.U., P = 0.093, n = 53, Figure 3.3A,B). While 10 µM ML204 was still
present, the NO donor SNAP caused a significant increase in cytosolic Ca2+ by 6.2 %
(10 µM ML204, 8.09 ± 0.58 A.U., 10 µM ML204/SNAP, 8.6 ± 0.56 A.U., P = 0.001, n =
53, Figure 3.3A,B). Cytosolic Ca2+ remained elevated when 10 µM ML204 was removed
and only SNAP remained (10 µM ML204/SNAP, 8.6 ± 0.56 A.U., SNAP, 8.78 ± 0.61
A.U., P = 0.46, n = 53, Figure 3.3A,B). Also, 10 µM ML204 did not block the NOdependent increase in sPSC frequency (10 µM ML204, 13.06 ± 2.5/30 s, 10 µM
ML204/SNAP, 21.78 ± 3.7/30 s, P = 0.027, n = 9, Figure 3.3C,D). sPSC frequency
remained elevated when 10 µM ML204 was removed and only SNAP remained (10 µM
ML204/SNAP, 21.78 ± 3.7/30 s, SNAP, 40.08 ± 18.9/30 s, P = 0.3, n = 9, Figure
3.3C,D). To further test the effectiveness of ML204 on the NO response, the
concentration of ML204 was increased to 20 µM. Co-application of 20 µM ML204 and
SNAP blocked the NO-dependent increase in cytosolic Ca2+ (20 µM ML204, 6.6 ± 0.3
A.U., 20 µM/SNAP, 6.51 ± 0.3 A.U., P = 0.15, n = 102, Figure 3.3E,F) and the NOdependent increase in sPSC frequency (20 µM ML204, 20.38 ± 4.8/30 s, 20 µM
ML204/SNAP, 23.78 ± 5.5/30 s, P = 0.48, n = 12, Figure 3.3G,H). When 20 µM ML204
was removed and only SNAP remained, NO caused a significant increase in cytosolic
Ca2+ by 5.3% (20 µM ML204/SNAP, 6.51 ± 0.3 A.U., SNAP, 6.85 ± 0.32 A.U., P <
0.0001, n = 102, Figure 3.3E,F) and in sPSC frequency by 70% (20 µM ML204/SNAP,
23.78 ± 5.5/30 s, SNAP, 35.35 ± 6.7/30 s, P = 0.02, n = 12, Figure 3.3G,H). The ability
for ML204 to block the NO-dependent response at 20 µM but not 10 µM suggests that
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NO is acting on TRPC5, not TRPC4, to activate the NO-dependent Ca2+ influx pathway
to enhance Ca2+-dependent GABA release.

Figure 3.3. The TRPC4/C5 inhibitor ML204 can block the NO-dependent increase in
cytosolic Ca2+ and sPSC frequency at higher concentrations. A: co-application of 10 µM
ML204 and NO donor SNAP did not prevent the NO-dependent increase in cytosolic Ca2+.
Cytosolic Ca2+ remained elevated upon removal of 10 µM ML204 from the bath. B:
quantified mean fluorescence ± SE; n = 53. C: current recording from a representative
amacrine cell voltage clamped at -70 mV. 10 µM ML204 was not effective at blocking the
NO-dependent increase in sPSC frequency. D: quantified mean event frequency/30 s ±
SE; n = 13. E: 20 µM ML204 blocked the NO-dependent increase in cytosolic Ca2+. NO
increased cytosolic Ca2+ after removing 20 µM ML204 from the bath and SNAP remained.
F: quantified mean fluorescence ± SE; n = 102. G: current recording from a representative
amacrine cell voltage clamped at -70 mV. 20 µM ML204 blocked the NO-dependent
increase in sPSC frequency. NO increased sPSC frequency upon removal of 20 µM
ML204 from the bath and SNAP remained. H: quantified mean event frequency/30 s ±
SE; n = 12. *P < 0.05, **P < 0.01, ***P < 0.001. ***P < 0.0001, ns, not significant.
Fluorescence over time data are plotted as mean fluorescence ± SE.
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TRPC5 is expressed in ACs in culture and retina
Inhibitors for the TRPC channels are not completely specific for a single TRPC
family member, however, previous experiments using clemizole, which preferentially
inhibits TRPC5 (Maddox and Gleason 2017), blocked NO-dependent dendritic Ca2+
elevations and the increase in sPSC frequency. Here, 10 µM ML204 did not block the
NO response, however, 20 µM ML204 blocked the NO-dependent increase in cytosolic
Ca2+ and the increase in sPSC frequency (Figure 3.3). The results using these two
inhibitors suggests that NO may be activating TRPC5, not TRPC4, to admit Ca2+ into
the presynaptic terminal and enhance vesicular GABA release. To determine if ACs in
culture and the adult retina express TRPC5, we used a monoclonal TRPC5 antibody
raised against amino acids 534 – 603 of the human TRPC5 protein (96% antigen
homology with the chicken TRPC5). This antibody recognizes a single band in a
western blot around the appropriate molecular weight of TRPC5 (112 kDa) in chicken
brain homogenate (Figure 3.4A). The TRPC5 antibody recognizes cell bodies and
processes in cultured ACs (Figure 3.4B) and AC bodies (arrowheads, Figure 3.4C) and
processes arising from AC bodies into the IPL (arrowheads, Figure 3.4D) in the retina.
Additionally, there was TRPC5 labeling in Müller cell bodies in the INL (arrows, Figure
3.4C) and in cell bodies in the GCL (asterisks, Figure 3.4C). The punctate TRPC5
labeling pattern in the IPL, where ACs form synapses, suggests that TRPC5 forms
clusters in the IPL, possibly at AC presynaptic terminals.
CRISPR/Cas9-mediated dsDNA break of the TRPC5 gene reduces TRPC5 expression
To confirm that TRPC5 is the Ca2+ permeable channel involved in the NO
response, a CRISPR/Cas9 system targeting the TRPC5 gene was developed to induce
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Figure 3.4. Amacrine cells in culture and adult retina express TRPC5. A: Western blot
for TRPC5 in chicken brain protein with the monoclonal TRPC5 (1C8 clone) antibody
recognizes a single band at the appropriate molecular weight (112 kDa). B: an amacrine
cell in culture immunolabeled with the TRPC5 antibody and DNA marker DAPI. C: adult
chicken retina immunolabeled with the TRPC5 antibody. Likely Müller cell bodies
(arrows) and amacrine cell bodies (arrow heads) within the INL are clearly labeled. Cell
bodies in the GCL are also labeled (asterisks). Strong punctate labeling is present in the
IPL, suggesting that TRPC5 clusters within processes D: expanded view of the box in C.
TRPC5 is present within a process arising from an amacrine cell body (arrow heads). PR,
photoreceptors; OPL, outer plexiform layer; INL, inner nuclear layer; IPL, inner plexiform
layer; GCL, ganglion cell layer.
dsDNA breaks in the 2nd exon of the TRPC5 gene (Ran et al. 2013). After dsDNA
breaks, the cellular DNA repair machinery will generate insertions/deletions (indels) at
the site of the dsDNA break, which will lead to reduced expression or expression of nonfunctional protein. To confirm that a Cas9-mediated dsDNA break within the 2nd exon of
TRPC5 promoted indels, we employed the T7 endonuclease I (T7E1) mutation
detection assay (NEB). Heteroduplexed PCR products of the TRPC5 2nd exon from
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cultures transfected with the control plasmid pSpCas9-tdTomato were not digested by
T7E1, therefore, no indels were present (Figure 3.5A, left lane, control). Cultures
transfected with pCRISPR-TRPC5 contained indels because heteroduplexed PCR
products were digested by T7E1 into the predicted sizes based on the Cas9-targeted
cut site (Figure 3.5A, right lane, TRPC5 KD).
To confirm CRISPR/Cas9-mediated TRPC5 dsDNA breaks lead to reduced
expression of TRPC5, ACs that were transfected with either pSpCas9-tdTomato
(control, Figure 3.5B-D & Bi-Di) or pCRISPR-TRPC5 (TRPC5 KD, Figure 3.5E-G & EiGi) were immunolabeled using the same TRPC5 antibody in Figure 3.4. CRISPR/Cas9mediated dsDNA breaks in the TRPC5 gene reduced total dendritic TRPC5 labeled
area (control, 9.67 ± 1.0 µm2, n = 30, TRPC5 KD, 1.95 ± 0.2 µm2, n = 43, P < 0.0001,
Welch’s t-test, Figure 3.5H), TRPC5 object size (control, 125.4 ± 12.41 nm2, n = 30,
TRPC5 KD, 76.36 ± 3.66 nm2, n = 43, P = 0.0006, Welch’s t-test, Figure 3.5I), and
TRPC5 object intensity (control, 15019 ± 1419 A.U., n = 30, TRPC5 KD, 11454 ± 789.4
A.U., n = 43, P = 0.03, Welch’s t-test, Figure 3.5J). There was no significant difference
in tdTomato fluorescence within the TRPC5 object domain (control, 120103 ± 12018
A.U., n = 30, TRPC5 KD, 101802 ± 7154 A.U., n = 43, P = 0.2, Welch’s t-test, Figure
5K).
TRPC5 is required for the NO-dependent increase in cytosolic Ca2+ and GABA release
The CRISPR/Cas9-mediated knockdown of TRPC5 was used to investigate the
role of TRPC5 in the NO-dependent Ca2+ influx and enhancement of GABA release. In
ACs transfected with the control plasmid pSpCas9-tdTomato, NO caused a 3% increase
in cytosolic Ca2+ (control, 6.28 ± 0.39 A.U., SNAP, 6.5 ± 0.39 A.U., n = 149, P < 0.0001,
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Figure 3.5. CRISPR/Cas9-mediated TRPC5 mutagenesis reduces TRPC5 expression in
amacrine cell processes. A: T7 endonuclease I (T7EI) indels (insertions/deletions)
detection assay. The 2nd TRPC5 exon genomic DNA region from cultures transfected with
either pSpCas9-tdTomato (Control) or pCRISPR-TRPC5 (TRPC5 KD) was PCR
amplified, denatured, and slowly reannealed to form mismatched heteroduplex DNA
(hdDNA). hdDNA was then digested with T7EI, which recognizes mismatched
nucleotides. T7EI only recognized and digested hdDNA mismatched nucleotides from
TRPC5 KD into predicted sizes (408 bp and 313 bp). B-G, amacrine cells transfected
with pSpCas9-tdTomato (Control, B-D) or pCRISPR-TRPC5 (TRPC5 KD, E-G) and
immunolabeled for TRPC5. Scale bars, 10 µm. Insets in B-G correspond to Bi-Gi,
respectively. Scale bars, 5 µm. H-K, quantification of TRPC5 labeling in processes from
pSpCas9-tdTomato (control) and pCRISPR-TRPC5 (TRPC5 KD) transfected cells.
TRPC5 KD significantly reduced the total area of TRPC5 immunofluorescence (H),
TRPC5 object size (> 5 pixels, I), intensity (int.) of TRPC5 object (> 5 pixels)
immunofluorescence (J), and TRPC5 immunofluorescence intensity that falls within
tdTomato fluorescence (K). Mean (dotted line) ± SE. All data points are plotted. Control
(light grey circles), n = 30. TRPC5 KD (dark grey circles), n = 43. *P < 0.05, ***P < 0.001
****P < 0.0001 (Welch’s t-test).
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Figure 3.6A-B) and a 47.5% increase in sPSC frequency (control, 16.5 ± 4.2/30 s,
SNAP, 24.3 ± 4.7/30 s, n = 9, P = 0.009, Figure 3.6C-D). In ACs transfected with
pCRISPR-TRPC5, NO did not increase cytosolic Ca2+ (control, 4.53 ± 0.23 A.U., SNAP,
4.44 ± 0.23 A.U., n = 255, P < 0.0001, Figure 3.6E-F) and did not increase sPSC
frequency (control, 19.84 ± 4.99/30 s, SNAP, 20.11 ± 5.55/30 s, n = 9, P = 0.78, Figure
3.6G-H). These data confirm that TRPC5 is required for the NO-dependent influx of
Ca2+ into the presynaptic terminal and enhanced Ca2+-dependent vesicular GABA
release.
Discussion
To our knowledge, this is the first report demonstrating that a member of the
canonical TRP family, TRPC5, mediates NO-dependent vesicular neurotransmitter
release at a GABAergic synapse. Here, we find the action of NO on sPSC frequency is
dependent on downstream activity of PLC, is blocked with 2 mM La3+, and is enhanced
by 10 µM La3+. The requirement of PLC activity and dual effects of La3+ are
characteristic of TRPC4 and TRPC5 channels. The TRPC4/C5 inhibitor ML204 at 10
µM did not block the NO response, however 20 µM ML204 prevented the NOdependent increase in dendritic Ca2+ and sPSC frequency. CRISPR/Cas9-mediated
genetic knockdown of TRPC5 using a guide RNA designed to target Cas9 to the 2nd
exon of TRPC5 precluded an NO-dependent increase in dendritic Ca2+ and sPSC
frequency. Additional evidence that further supports TRPC4 is not involved in the NOresponse is provided by previous work in the Gleason lab that demonstrated TRPC4 is
not expressed by ACs in culture or by ACs in adult retina (Crousillac et al. 2003). These
results confirm that NO enhances voltage-independent vesicular neurotransmitter
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Figure 3.6. Knockdown of TRPC5 eliminates the NO-dependent increase in cytosolic Ca2+
and sPSC frequency. A-D, data from amacrine cells transfected with pSpCas9-tdTomato
(Control). A, The NO-dependent increase in cytosolic Ca2+ in amacrine cell processes
was still present in control cells. B, quantified mean fluorescence ± SE, n = 149. ****P <
0.0001. C, recording from a representative amacrine cell voltage clamped at -70 mV and
in contact with other transfected amacrine cells. SNAP still caused an increase in sPSC
frequency in cells transfected pSpCas9-tdTomato. D, quantified mean event
frequency/30 s ± SE; n = 9. **P < 0.01, paired t-test. E-F, data from amacrine cells
transfected with pCRISPR-TRPC5 (TRPC5 KD). E, The NO-dependent increase in
cytosolic Ca2+ was absent in amacrine cells transfected with pCRISPR-TRPC5. F,
quantified mean fluorescence ± SE; n = 255. G, recording from a representative amacrine
cell transfected with the pCRISPR-TRPC5. Cells were voltage clamped at -70 mV and
were in contact with other transfected amacrine cells. SNAP was unable to cause an
increase in sPSC frequency in cells transfected with pCRISPR-TRPC5. H, quantified
mean event frequency/30 s ± SE; n = 9. P = 0.78 (paired t-test).
release at retinal AC GABAergic synapses via a TRPC5-mediated Ca2+ influx into the
presynaptic terminal.
TRPC5 in the retina and brain
First identified in a Drosophila melanogaster mutant screen for visual defects
(Cosens and Manning 1969), the transient receptor potential (TRP) channel was named
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due to the shortened response of photoreceptors under intense illumination (Minke
2010; Minke et al. 1975). Almost all members of the TRP channel superfamily are
expressed with varying degree in the vertebrate retina, however, the role of TRP
channels in visual signal processing in the vertebrate retina remains to be fully explored.
Recent work has identified a vertebrate TRP channel of the melastatin subfamily,
TRPM1, necessary for depolarizing light responses of retinal ON-bipolar cells (Koike et
al. 2010; Morgans et al. 2009). Additionally, patients that suffer from complete
congenital stationary night blindness have a TRPM1 gene mutation (Audo et al. 2009;
Nakamura et al. 2010). Here, we identified a TRP channel in the canonical subfamily,
TRPC5, that may be involved in processing the visual signal by enhancing GABAergic
inhibition in the inner retina.
In the brain, studies have identified that TRPC5 has an essential role in dendritic
length, patterning, and growth cone morphology in developing hippocampal neurons
(Greka et al. 2003; He et al. 2012; Puram et al. 2011). One study found that binding of
epidermal growth factor leads to a rapid insertion of readily available vesicles containing
TRPC5, and this pathway is needed for proper hippocampal neuron development
(Bezzerides et al. 2004). The role of TRPC5 in mature neurons is not fully understood.
Two studies, however, have identified separate roles for TRPC5 in mature neurons in
the brain including innate fear processing in the amygdala (Riccio et al. 2009) and
seizures and seizure-induced cell death in the hippocampus (Phelan et al. 2013). To
date, there are no published studies investigating the physiological role of TRPC5 in the
retina.
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In the mouse retina, TRPC5 expression is inner row of the inner nuclear layer
(INL) where AC bodies lie (Gilliam and Wensel 2011). However, a separate study
characterizing dopaminergic interplexiform processes in the mouse retina found TRPC5
immunolabeling to be mostly restricted to the synaptic layers, inner plexiform layer (IPL)
and outer plexiform layer (OPL) (Witkovsky et al. 2008). The TRPC5 labeling pattern
presented here is comparable to the mouse retina and was found to be in cell bodies
within the inner half of the INL (likely Müller cells and ACs) and cell bodies in the
ganglion cell layer. Additionally, there was extensive punctate labeling within the IPL.
The punctate labeling within the IPL suggests that TRPC5 might form clusters at
possible synaptic sites, however, synaptic localization of TRPC5 within the retina
remains unknown.
Identification of NO-dependent activation of TRPC5
PLC downstream activity is known to be an activator of all TRPC channels,
however, the PLC activity-dependent activation of each TRPC family member is not fully
understood. Two studies have demonstrated that TRPC4 (Otsuguro et al. 2008) and
TRPC5 (Obukhov and Nowycky 2004; Trebak et al. 2009) are inhibited by
phosphatidylinositol 4,5-bisphosphate (PIP2) and become activated once PLC relieves
this inhibition by cleaving PIP2 into inositol trisphosphate (IP3) and diacylglycerol (DAG).
A previous study using the global PLC inhibitor U73122 and the disulfide agent 2,2’dithiobis(5-nitropyridine) demonstrated in an over expression system that direct
activation of TRPC5 via cysteine thiol modification did not require PLC activity (Yoshida
et al. 2006). The results presented here suggest that that PLC activity is require for the
NO-dependent activation of TRPC5 and increase in sPSCs. U73122, however, also

74

abolished almost all baseline sPSCs. This suggests S-nitrosylation-dependent
activation of natively expressed TRPC5 in ACs may not overcome the PLC-dependence
of spontaneous GABA release. Of the two known mechanisms in which NO functions
(the NO-sGC pathway and S-nitrosylation), we previously established that the NO-sGC
pathway is not involved in the NO response. Although the exact mechanism in which
NO activates TRPC5 to enhance vesicular GABA release remains unknown, TRPC5
may have a physiological role in the inner retina to enhance inhibition.
Effects of NO on amacrine cells
NO has previously been shown to enhance the release of GABA in all layers of
the turtle retina (Yu and Eldred 2005), however, this was indirectly demonstrated by the
NO-dependent reduction in labeling of a preloaded GABA analog, g-vinyl-GABA (GVG)
(Yu and Eldred 2005). Interestingly, the NO-dependent reduced GVG labeling was
largely dependent on extracellular Ca2+ in the IPL, which is where processes from
amacrine cells ramify and form synapses (Yu and Eldred 2005). Another study found
that NOS-stimulated NO production with its substrate L-arginine dampens both ON and
OFF light responses in all major ganglion cell types, with the OFF response being the
most sensitive to NO (Wang et al. 2003). Since NO only affected the intrinsic ganglion
cell membrane properties of a small population of each ganglion cell type, it was
suggested that NO works at a site immediately presynaptic to ganglion cells (likely
amacrine cells) to increase inhibition and dampen the light responses (Wang et al.
2003). Incorporating the findings of these two studies with the findings in my
dissertation, NO may have reduced ganglion cell light responses (Wang et al. 2003) by
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increasing Ca2+-dependent GABA release (Yu and Eldred 2005) through the NOdependent TRPC5-mediated Ca2+ influx into amacrine cells.
Multiple effects of NO on amacrine cell synapses
We previously demonstrated that NO activates a Ca2+ influx pathway that is
sufficient to drive vesicular exocytosis and GABA release without depolarization
(Maddox and Gleason 2017). Here, using the TRPC4/C5 inhibitor ML204 and
CRISPR/Cas9-mediated knockdown of gene expression, we identify the channel
responsible for the NO-dependent Ca2+ influx as TRPC5. Previous work in the Gleason
lab determined that higher concentrations of NO (~2 µM) transiently alter inhibitory
postsynaptic voltage responses in ACs by releasing Cl- from internal acidic
compartments (Hoffpauir et al. 2006; Krishnan and Gleason 2015). This Cl- release
shifts the reversal potential of GABA-gated currents more positive and changes
postsynaptic voltage responses to less inhibitory or even excitatory. Taken together,
these results suggest that locally generated NO in the inner retina can affect both preand postsynaptic sites: voltage-independent GABA release is enhanced and GABA
action on the postsynaptic amacrine cell can lead to depolarization. If these actions cooccur, then they will enhance inhibitory output from the downstream AC (See Figure
3.7). The patterns of NO production under different stimulus conditions will determine
the sites of enhanced GABAergic output and thus the impact on the signals that
ganglion cells send to visual centers in the brain.
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Figure 3.7. NO has pre- and postsynaptic effects in ACs. A: Simplified cartoon of a
GABAergic AC (light grey) in the retina receiving glutamatergic input from a bipolar cell
(BC) and presynaptic to another AC (Left). NO synthesis in a NOS expressing AC (red)
can elicit changes in both pre- and postsynaptic processes (Right). B: Expanded view of
the box in A, depicting presynaptic and postsynaptic effects of NO. Top, Activation of a
Ca2+-dependent isoform of NOS (eNOS or nNOS) produces NO (1.). NO activates
TRPC5, possibly via S-nitrosylation (S-NO?), to admit Ca2+ into the presynaptic terminal
(2.). Ca2+ elevations in the presynaptic terminal lead to increased vesicle fusion events
and GABA release (3.) onto its postsynaptic partner. VGCC, voltage-gated Ca2+ channel;
GluR, ionotropic glutamate receptor. Bottom, NO diffuses into the postsynaptic terminal
and induces Cl- release from acidic organelles (4., Krishnan and Gleason, 2015).
Increased [Cl-] in the postsynaptic terminal reverses the Cl- gradient, converting typical
GABAergic inhibition into depolarization (5., Hoffpauir et al. 2006). Depolarization (+)
leads to activation of VGCCs in an adjacent presynaptic site in the same process (6.).
Ca2+ influx through activated VGCCs leads to enhanced GABA release (7.). The
postsynaptic partner that is downstream from the targets of NO will experience increased
inhibition (8.).
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CHAPTER 4
CONCLUSIONS
In Chapter 2, I provide direct evidence that NO enhances neurotransmitter
release at retinal AC GABAergic synapses, independent of the canonical NO receptor,
sGC, and presynaptic action potentials. Ca2+ imaging at regions of process contacts
and whole-cell current recordings of spontaneous and evoked GABA release revealed
that NO activates a Ca2+ influx pathway, independent of Ca2+ release from stores. The
TRPC inhibitor clemizole, which preferentially blocks TRPC5, blocked the NOdependent Ca2+ elevation and the increase in sPSC frequency. Since NO is
endogenously produced in vertebrate retinas (Blom et al. 2012; Eldred and Blute 2005;
Tekmen-Clark and Gleason 2013), these findings suggest that NO enhances inhibition
by activating a TRPC-mediated Ca2+ influx and enhancing Ca2+-dependent vesicular
GABA release from ACs.
In Chapter 3, I determined that the Ca2+ permeable, nonselective cation channel
TRPC5 mediates the NO-dependent Ca2+ influx and increase in GABA release. The first
pieces of evidence that suggested the involvement TRPC5 was that downstream PLC
activity is required and that 2 mM La3+ blocks and 10 µM La3+ enhances the NOdependent response. The requirement of PLC activity and the dual effects of La3+ on
the NO response are unique characteristics of TRPC4 and TRPC5 channel activity.
ML204, another TRPC inhibitor that preferentially blocks TRPC4, had no effects on the
NO-dependent Ca2+ elevations or increase in sPSC frequency, suggesting the
involvement of TRPC5 and not TRPC4. Previous work in the Gleason lab demonstrated
that TRPC4 is not expressed by ACs in culture or in the adult retina, further suggesting
that TRPC4 is not involved. Immunolabeling experiments in my dissertation revealed
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that TRPC5 is expressed by ACs both in culture and in the adult retina. Using the
CRISPR/Cas9 system, genetic knockdown of protein expression allowed me to correctly
identify the involvement of TRPC5 in the NO response. Reduced TRPC5 expression in
transfected ACs precluded the NO-dependent Ca2+ elevation and the NO-dependent
increase in sPSC frequency. Since ACs in the retina can produce NO and express
TRPC5, these findings suggest that NO enhances GABAergic inhibition in the inner
retina by activating TRPC5.
TRPC5 has been shown to be directly activated by S-nitrosylation (Yoshida et al.
2006). In my experiments, the mechanism in which NO activates TRPC5 remains
unknown. To admit Ca2+ into the presynaptic terminal and promote Ca2+-dependent
GABA release, NO may directly activate TRPC5 via S-nitrosylation, may act on an
unidentified regulator of TRPC5 activity, or a combination of both. A western blot using
immunoprecipitated TRPC5 after exposure to NO and probed for S-nitrosylation using
“S-NO” antibodies, which recognize cysteine S-nitrosothiols, would reveal if native
TRPC5 expressed in ACs becomes S-nitrosylated. To investigate if TRPC5 is being
activated via S-nitrosylation, experiments using a mutated version of TRPC5 lacking the
cysteine resides needed for S-nitrosylation could be overexpressed in these cells to see
if the NO-dependent Ca2+ influx absent. This would reveal if S-nitrosylation is the mode
in which NO activates the TRPC5-mediated Ca2+ influx.
Previously, it has been indirectly demonstrated that NO enhances Ca2+
dependent GABA release in the turtle inner retina due to NO-dependent reduced
labeling of the preloaded GABA analog GVG (Yu and Eldred 2005). Additionally,
another study found that NOS-stimulated NO production reduced ganglion cell ON and
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OFF light responses, with the OFF response being the most sensitive to NO (Wang et
al. 2003). The reduced light responses were not due to intrinsic changes in ganglion cell
membrane properties, suggesting that NO acts on a presynaptic site to enhance
inhibition onto the ganglion cells. Because they are the only cells presynaptic to
ganglion cells that provide inhibitory signals, ACs are likely the site in which NO acts.
Combining the findings of these two studies with findings in my dissertation, NO may
have reduced ganglion cell light responses (Wang et al. 2003) by increasing Ca2+dependent GABA release (Yu and Eldred 2005) through the NO-dependent TRPC5mediated Ca2+ influx in ACs.
The physiological role of TRPC channels in the retina remains unclear. Future
experiments using transgenic knockout models must be performed to validate this
pathway by recording from cells in retinal slices that are postsynaptic to ACs (bipolar
cells, ganglion cells or other ACs). The use of nNOS knockout mice to investigate this
pathway would not produce reliable results. In a previous study, ganglion cell light
responses in nNOS knockout mice required brighter light stimuli compared to normal
mice, suggesting NO produced by nNOS is important for phototransduction in
photoreceptors (Wang et al. 2007). Experiments using commercially available TRPC5
knockout mice would confirm if ACs expressing TRPC5 are responsible for the NOdependent enhanced inhibition, without interrupting other NO-dependent mechanisms
due to the loss of nNOS expression. If this nNOS-NO-TRPC5 pathway enhances
GABAergic inhibition, ganglion cell light responses in TRPC5 knockout mice will be
enhanced due to the loss of NO-dependent activation of TRPC5.
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This enhanced NO-dependent GABAergic signaling at AC synapses may be
highly localized. Activation of NMDA ionotropic glutamate receptors (NMDARs), coupled
to a Ca2+-dependent NOS isoform (nNOS or eNOS), initiates NO production in the turtle
retina (Blute et al. 2000). In the chicken retina, NMDAR activation increases NO
production predominately in the INL and IPL (Tekmen-Clark and Gleason 2013). AC
synaptic terminals can have multiple presynaptic sites, and in the turtle retina, nNOS
can be present at one presynaptic site and absent at an adjacent presynaptic site within
the same AC synaptic terminal (Cao and Eldred 2001; Eldred and Blute 2005). Lightdependent and -independent activation of ON bipolar cells and OFF bipolar cells,
respectively, provides glutamatergic input onto ACs. Activation of both pathways leads
to increases NO production in the mouse retina (Blom et al. 2012) and salamander
retina (Eldred and Blute 2005). Since the NO-dependent release of GABA is voltageindependent, NO produced at one AC presynaptic site would eliminated the need for
depolarization by diffusing to adjacent presynaptic sites and enhance NO-dependent
GABA release from multiple presynaptic sites within the same AC synaptic terminal.
This would enhance GABAergic inhibition of postsynaptic cell (s). Furthermore, if
sufficient NO is produced and the postsynaptic cell receiving increased NO-dependent
GABAergic input is another AC, NO would release intracellular Cl-, invert sign of the
GABAergic input, and drive depolarization-dependent GABA release from the
postsynaptic AC. This NO-dependent amplification of GABA release may be a
mechanism needed to provide sufficient inhibition to properly process visual signals
during prolonged light stimulation.
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